{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_0", "document_index": 50, "latency_s": 55.2958251000091, "prompt_toks": 28458, "completion_toks": 79}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprobamate\n\nPubChem CID\n\n4064\n\nStructure\n\nMeprobamate_small.png\n\nMeprobamate_3D_Structure.png\n\nChemical Safety\n\nIrritant\n\nLaboratory Chemical Safety Summary (LCSS) Datasheet\n\nMolecular Formula\n\nC9H18N2O4\n\nSynonyms\n\nmeprobamate\n\nEquanil\n\nMeprospan\n\nMiltown\n\nMeprocompren\n\nMolecular Weight\n\n218.25 g/mol\n\nComputed by PubChem 2.2 (PubChem release 2025.04.14)\n\nDates\n\nCreate:\n\n2005-03-25\n\nModify:\n\n2025-04-19\n\nDescription\n\nMeprobamate can cause developmental toxicity according to state or federal government labeling requirements.\n\nMeprobamate appears as odorless white crystalline powder. Bitter taste. Solutions in water are neutral or slightly acidic. (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\nMeprobamate is an organic molecular entity.\n\n\n                    Context: \n                    This chunk is from the top summary box of the Meprobamate compound page, presenting key identifiers (name, synonyms, molecular formula, weight, PubChem CID), basic structural and safety information, and a brief physical and regulatory description. It serves as a concise overview before the document's detailed sections on properties, pharmacology, uses, toxicity, safety, environmental fate, and regulatory status.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_1", "document_index": 50, "latency_s": 53.42918899998767, "prompt_toks": 28646, "completion_toks": 100}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprobamate is an organic molecular entity.\n\nSee also: Aspirin; meprobamate (component of); Estrogens, conjugated; meprobamate (component of).\n\nContents\n\n1 Structures\n\n1.1 2D Structure\n\nChemical Structure Depiction\n\nMeprobamate.png\n\n1.2 3D Conformer\n\n2 Names and Identifiers\n\n2.1 Computed Descriptors\n\n2.1.1 IUPAC Name\n\n[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate\n\nComputed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)\n\n2.1.2 InChI\n\nInChI=1S/C9H18N2O4/c1-3-4-9(2,5-14-7(10)12)6-15-8(11)13/h3-6H2,1-2H3,(H2,10,12)(H2,11,13)\n\nComputed by InChI 1.07.2 (PubChem release 2025.04.14)\n\n2.1.3 InChIKey\n\nNPPQSCRMBWNHMW-UHFFFAOYSA-N\n\nComputed by InChI 1.07.2 (PubChem release 2025.04.14)\n\n2.1.4 SMILES\n\nCCCC(C)(COC(=O)N)COC(=O)N\n\nComputed by OEChem 2.3.0 (PubChem release 2025.04.14)\n\n2.2 Molecular Formula\n\nC9H18N2O4\n\nComputed by PubChem 2.2 (PubChem release 2025.04.14)\n\n2.3 Other Identifiers\n\n2.3.1 CAS\n\n57-53-4\n\n2.3.2 European Community (EC) Number\n\n200-337-5\n\n2.3.3 UNII\n\n9I7LNY769Q\n\n\n                    Context: \n                    This section provides the core chemical identity and structure information for meprobamate, including its classification as an organic molecular entity, related compounds for reference, and key identifiers such as IUPAC name, InChI, InChIKey, SMILES notation, molecular formula, and registry numbers (CAS, EC, UNII). It serves as the foundation for understanding and cross-referencing meprobamate's chemical properties, nomenclature, and database records within the broader compound profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_2", "document_index": 50, "latency_s": 56.47752490002313, "prompt_toks": 28657, "completion_toks": 124}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    C9H18N2O4\n\nComputed by PubChem 2.2 (PubChem release 2025.04.14)\n\n2.3 Other Identifiers\n\n2.3.1 CAS\n\n57-53-4\n\n2.3.2 European Community (EC) Number\n\n200-337-5\n\n2.3.3 UNII\n\n9I7LNY769Q\n\n2.3.4 ChEBI ID\n\nCHEBI:6761\n\n2.3.5 ChEMBL ID\n\nCHEMBL979\n\n2.3.6 DEA Code Number\n\n2820 (DEA schedule IV controlled substance)\n\n2.3.7 DrugBank ID\n\nDB00371\n\n2.3.8 DSSTox Substance ID\n\nDTXSID3023261\n\n2.3.9 HMDB ID\n\nHMDB0014515\n\n2.3.10 KEGG ID\n\nD00376\n\n2.3.11 Metabolomics Workbench ID\n\n42739\n\n2.3.12 NCI Thesaurus Code\n\nC47603\n\n2.3.13 Nikkaji Number\n\nJ4.475J\n\n2.3.14 NSC Number\n\n30418\n\n2.3.15 PharmGKB ID\n\nPA450377\n\n2.3.16 Pharos Ligand ID\n\nU8J1VCH94777\n\n2.3.17 RXCUI\n\n6760\n\n2.3.18 Wikidata\n\nQ418351\n\n2.3.19 Wikipedia\n\nMeprobamate\n\n2.4 Synonyms\n\n2.4.1 MeSH Entry Terms\n\nDapaz\n\nEquanil\n\nMéprobamate Richard\n\nMeprobamate\n\nMeprospan\n\nMiltown\n\nTranmep\n\nVisano\n\n2.4.2 Depositor-Supplied Synonyms\n\nmeprobamate\n\nEquanil\n\nMeprospan\n\nMiltown\n\nMeprocompren\n\nAmepromat\n\nMeprobam\n\nMeprobamat\n\nMeproban\n\nNeuramate\n\nAmosene\n\nMepriam\n\n\n                    Context: \n                    This chunk appears in the \"Names and Identifiers\" section of the Meprobamate compound page. It provides the molecular formula (C9H18N2O4), followed by a comprehensive list of key chemical identifiers used in various chemical, pharmaceutical, and regulatory databases (such as CAS, EC, DrugBank, KEGG, ChEBI, and more). It then lists a range of synonyms, including both standardized medical synonyms (MeSH entry terms) and a selection of depositor-supplied or commercial names. This information supports precise identification of meprobamate across different scientific and regulatory contexts.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_3", "document_index": 50, "latency_s": 62.42679769999813, "prompt_toks": 28654, "completion_toks": 99}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprospan\n\nMiltown\n\nTranmep\n\nVisano\n\n2.4.2 Depositor-Supplied Synonyms\n\nmeprobamate\n\nEquanil\n\nMeprospan\n\nMiltown\n\nMeprocompren\n\nAmepromat\n\nMeprobam\n\nMeprobamat\n\nMeproban\n\nNeuramate\n\nAmosene\n\nMepriam\n\nTranmep\n\n57-53-4\n\nAnastress\n\nAnathylmon\n\nAyeramate\n\nBiobamate\n\nCrestanil\n\nDespasmol\n\nDicandiol\n\nEquatrate\n\nHolbamate\n\nMepiosine\n\nMeprindon\n\nMeproleaf\n\nMeprotabs\n\nMetractyl\n\nMetranquil\n\nMiltamato\n\nAnatimon\n\nAndaksin\n\nAndaxin\n\nAneural\n\nAnsiatan\n\nAnsiowas\n\nAnxietil\n\nApascil\n\nArcoban\n\nArtolon\n\nAuxietil\n\nBiobamat\n\nCalmadin\n\nCalmiren\n\nCarbaxin\n\nCirponyl\n\nEcuanil\n\nEnorden\n\nEquitar\n\nEstasil\n\nGadexyl\n\nHarmonin\n\nIpsotian\n\nLepenil\n\nLepetown\n\nLibiolan\n\nMargonil\n\nMepantin\n\nMepavlon\n\nMeposed\n\nMepranil\n\nMeprocon\n\nMeprodil\n\nMeprosa\n\nMeprosan\n\nMeprosin\n\nMeprotan\n\nMeprotil\n\nMeptran\n\nMilprem\n\nMiltaun\n\nAnsil\n\nAnural\n\nAnzil\n\nArpon\n\nCalmax\n\nCirpon\n\nCyrpon\n\nDapaz\n\nDiron\n\nEdenal\n\nEpicur\n\nEpikur\n\nErina\n\nHartol\n\nKlort\n\nLarten\n\nLetyl\n\nMendel\n\nMeprol\n\nKesso-Bamate\n\nMar-Bate\n\nMeprocon CMC\n\nDormabrol\n\nEquilium\n\n\n                    Context: \n                    This chunk appears within the extensive list of synonyms for meprobamate, specifically under the \"Depositor-Supplied Synonyms\" section. It catalogs various alternative names and brand names—such as Meprospan, Miltown, Tranmep, and Visano—that are used to identify the compound in different contexts and sources. This list supports chemical identification and information retrieval by associating meprobamate with its numerous global trade names, chemical names, and registry numbers.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_4", "document_index": 50, "latency_s": 53.484943899995415, "prompt_toks": 28635, "completion_toks": 51}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Anural\n\nAnzil\n\nArpon\n\nCalmax\n\nCirpon\n\nCyrpon\n\nDapaz\n\nDiron\n\nEdenal\n\nEpicur\n\nEpikur\n\nErina\n\nHartol\n\nKlort\n\nLarten\n\nLetyl\n\nMendel\n\nMeprol\n\nKesso-Bamate\n\nMar-Bate\n\nMeprocon CMC\n\nDormabrol\n\nEquilium\n\nMeprodiol\n\nAtraxin\n\nBamate\n\nDeprol\n\nDiurnal\n\nDiveron\n\nMilpath\n\n3P Bamate\n\nMeprovanmeprozine\n\nCanquil-400\n\nEquanil suspension\n\nMeptranactylmilprem\n\nMeprobamato\n\nMeprotanum\n\nMicrainin\n\nProcalmidol\n\nProcarbamide\n\nMeprin\n\nMepro-analgesic\n\nCap-O-Tran\n\nFas-Cile 200\n\nEquazine-M\n\nBamo 400\n\nDiurnaldiverondormabrol\n\nNephentine\n\nPathibamate\n\nPerequietil\n\nPerquietil\n\nPertranquil\n\nProcalmadiol\n\nProcalmadol\n\nSedabamate\n\nSedoselecta\n\nTrankvilan\n\nTranlisant\n\nTranquilan\n\nTranquilate\n\nTranquilax\n\nTranquiline\n\nTranquilsan\n\nTranquinol\n\nVistabamate\n\nAneurol\n\nAneusral\n\nAneuxal\n\nAneuxral\n\nAtaraxine\n\nAyermate\n\nBrobamate\n\nEquinil\n\nGagexyl\n\nMepamtin\n\nMiltann\n\nMiltuan\n\nMiltwon\n\nMultaun\n\nNervonus\n\nOptarket\n\nOrlevol\n\nOrolevol\n\nPancalma\n\nPanediol\n\nPankalma\n\nPensive\n\nPerequil\n\nPlacidon\n\nPlacitate\n\nPrequil\n\nProbamato\n\n\n                    Context: \n                    This chunk lists depositor-supplied synonyms and trade names for meprobamate, found within a larger section detailing extensive alternative names, synonyms, and brand names used for the compound across various sources, to support comprehensive identification during chemical or pharmaceutical information retrieval.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_5", "document_index": 50, "latency_s": 51.69620700000087, "prompt_toks": 28615, "completion_toks": 59}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Equinil\n\nGagexyl\n\nMepamtin\n\nMiltann\n\nMiltuan\n\nMiltwon\n\nMultaun\n\nNervonus\n\nOptarket\n\nOrlevol\n\nOrolevol\n\nPancalma\n\nPanediol\n\nPankalma\n\nPensive\n\nPerequil\n\nPlacidon\n\nPlacitate\n\nPrequil\n\nProbamato\n\nProbamyl\n\nPromate\n\nPromato\n\nProquanil\n\nProtran\n\nQuaname\n\nQuanane\n\nQuietidon\n\nRastenil\n\nReostral\n\nRestenil\n\nRestenyl\n\nRestinal\n\nRestinil\n\nRobamate\n\nSadanyl\n\nScolazil\n\nSedanil\n\nSedanyl\n\nSedazil\n\nSedoquil\n\nShalvaton\n\nSpantran\n\nStensolo\n\nTensonal\n\nTrelmar\n\nUrbilat\n\nWardamate\n\nWyseals\n\nApasil\n\nCypron\n\nMorbam\n\nOasil\n\nPaxin\n\nPimal\n\nQuanil\n\nQuivet\n\nSelene\n\nSeril\n\nSetran\n\nSowell\n\nTamate\n\nTensol\n\nUrbil\n\nZirpon\n\nPan-tranquil\n\nMeprobamat [German]\n\nVio-Bamate\n\nFas-Cile\n\nNeo-Tran\n\nMeprobamato [Italian]\n\nSK-Bamate\n\nSolevione anastress\n\nMeprobamatum\n\nAnsietan\n\nCoprobate\n\nKessobamate\n\nMeprospan-200\n\nMeprospan-400\n\nMeprovan\n\nMisedant\n\nMeprobamic acid\n\nMiltown 600\n\nMeprobamatum [INN-Latin]\n\nMy-trans\n\nMeprobamato [INN-Spanish]\n\n2,2-Di(carbamoyloxymethyl)pentane\n\nBamd 400\n\nMeprobamate civ\n\n\n                    Context: \n                    This chunk is part of an extensive synonyms list for Meprobamate, one of several subsections under \"2.4 Synonyms\" in the Names and Identifiers section, detailing various alternative, international, trade, and depositor-supplied names by which Meprobamate is known.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_6", "document_index": 50, "latency_s": 59.21716749999905, "prompt_toks": 28632, "completion_toks": 74}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprospan-400\n\nMeprovan\n\nMisedant\n\nMeprobamic acid\n\nMiltown 600\n\nMeprobamatum [INN-Latin]\n\nMy-trans\n\nMeprobamato [INN-Spanish]\n\n2,2-Di(carbamoyloxymethyl)pentane\n\nBamd 400\n\nMeprobamate civ\n\n1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate\n\n2-Methyl-2-propyltrimethylene carbamate\n\nPMB-200\n\nPMB-400\n\n2-Methyl-2-propyl-1,3-propanediol dicarbamate\n\n2-Methyl-2-n-propyl-1,3-propanediol dicarbamate\n\nDEA No. 2820\n\nHSDB 3117\n\nCarbamic acid, 2-methyl-2-propyltrimethylene ester\n\nEINECS 200-337-5\n\nUNII-9I7LNY769Q\n\nNSC-30418\n\nBRN 1788882\n\n9I7LNY769Q\n\n[2-(carbamoyloxymethyl)-2-methylpentyl] carbamate\n\nCarbamic acid 2-methyl-2-propyltrimethylene ester\n\nDTXSID3023261\n\n2-Metil-2-n-propil-1,3-propanediol dicarbamato\n\nDTXCID903261\n\nMeprobamate [USP:INN:BAN:JAN]\n\n2-[(carbamoyloxy)methyl]-2-methylpentyl carbamate\n\nNSC30418\n\nQ-GESIC COMPONENT MEPROBAMATE\n\nNSC 30418\n\nEQUAGESIC COMPONENT MEPROBAMATE\n\nMICRAININ COMPONENT MEPROBAMATE\n\n1,3-Propanediol, 2-methyl-2-propyl-, 1,3-dicarbamate\n\nMeprin (VAN)\n\n\n                    Context: \n                    This chunk is part of the extensive synonym and identifier list for meprobamate, presenting alternative names, chemical synonyms, trade names, regulatory codes, and database identifiers used internationally and across various chemical and pharmaceutical registries. It is located within the \"Names and Identifiers\" section of the document, supporting comprehensive search and cross-referencing for meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_7", "document_index": 50, "latency_s": 54.02976380000473, "prompt_toks": 28614, "completion_toks": 64}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    NSC30418\n\nQ-GESIC COMPONENT MEPROBAMATE\n\nNSC 30418\n\nEQUAGESIC COMPONENT MEPROBAMATE\n\nMICRAININ COMPONENT MEPROBAMATE\n\n1,3-Propanediol, 2-methyl-2-propyl-, 1,3-dicarbamate\n\nMeprin (VAN)\n\nNCGC00091031-01\n\nMeproten\n\nMeprobamatum (INN-Latin)\n\nMeprobamato (INN-Spanish)\n\nMEPROBAMATE (MART.)\n\nMEPROBAMATE [MART.]\n\nCanquil 400\n\nMEPROBAMATE (EP IMPURITY)\n\nMEPROBAMATE [EP IMPURITY]\n\nMEPROBAMATE CIV (USP-RS)\n\nMEPROBAMATE CIV [USP-RS]\n\nMeprobamate (USP:INN:BAN:JAN)\n\nMeprobamate and Aspirin Tablets\n\nMEPROBAMATE (USP MONOGRAPH)\n\nMEPROBAMATE [USP MONOGRAPH]\n\nCAS-57-53-4\n\nCarb-A-Med\n\nEquanil (TN)\n\nMiltown (TN)\n\ncomponent of Milpath\n\ncomponent of Milprem\n\nTranquiline (Intra)\n\ncomponent of Miltrate\n\ncomponent of Equalysen\n\ncomponent of PMB-400\n\nMicrobamat\n\nTranquilin\n\nAtraxine\n\nEqiagesic\n\nEquinal\n\nMarbate\n\nMeprobamate (JAN/USP/INN)\n\nMepr\n\n2-Metil-2-n-propil-1,3-propanediol dicarbamato [Spanish]\n\nMeprobamat-Petrasch\n\nMeprobamate Compound\n\nATARAXIN\n\nMeprin (meprobamate)\n\nMAR BATE\n\nPathibamate (Salt/Mix)\n\n\n                    Context: \n                    This chunk lists alternative names, trade names, formulations, and depositary identifiers for meprobamate, corresponding to its various synonyms in pharmaceutical, regulatory, and commercial contexts. It is part of a comprehensive section detailing meprobamate's synonyms and international identifiers, supporting cross-referencing across databases and product formulations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_8", "document_index": 50, "latency_s": 55.22996590001276, "prompt_toks": 28606, "completion_toks": 65}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprobamate (JAN/USP/INN)\n\nMepr\n\n2-Metil-2-n-propil-1,3-propanediol dicarbamato [Spanish]\n\nMeprobamat-Petrasch\n\nMeprobamate Compound\n\nATARAXIN\n\nMeprin (meprobamate)\n\nMAR BATE\n\nPathibamate (Salt/Mix)\n\nMEPROBAMATE [MI]\n\nMEPROBAMATE [INN]\n\nMEPROBAMATE [JAN]\n\nMEPROBAMATE [HSDB]\n\nCHEMBL979\n\nMEPROBAMATE [VANDF]\n\nSCHEMBL15286\n\nMEPROBAMATE [WHO-DD]\n\nMLS003899229\n\nCHEBI:6761\n\nGTPL7225\n\nMeprobamate, analytical standard\n\ncomponent of Deprol (Salt/Mix)\n\ncomponent of Milpath (Salt/Mix)\n\ncomponent of Milprem (Salt/Mix)\n\nMeprobamate, 1mg/ml in Methanol\n\nWLN: ZVO1X3&1&1OVZ\n\nMEPROBAMATE [ORANGE BOOK]\n\nN05BC01\n\ncomponent of Miltrate (Salt/Mix)\n\nKXB10666\n\nMeprobamate 1.0 mg/ml in Methanol\n\ncomponent of PMB-400 (Salt/Mix)\n\nTox21_111063\n\nTox21_200332\n\n1, 2-methyl-2-propyl-, dicarbamate\n\nAKOS003617983\n\nDB00371\n\nFM25071\n\nMEPROBAMATE COMPONENT OF Q-GESIC\n\nMEPROBAMATE COMPONENT OF EQUAGESIC\n\nMEPROBAMATE COMPONENT OF MICRAININ\n\nNCGC00091031-02\n\nNCGC00257886-01\n\nMEPRO-ASPIRIN COMPONENT MEPROBAMATE\n\n\n                    Context: \n                    This chunk lists various synonyms, trade names, registry numbers, and identifiers associated with meprobamate from multiple sources and languages. It is part of an extensive section detailing all known alternate names and identifiers for meprobamate, aiding in cross-referencing this compound across regulatory, pharmaceutical, chemical, and commercial databases.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_9", "document_index": 50, "latency_s": 56.18793939999887, "prompt_toks": 28579, "completion_toks": 72}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    DB00371\n\nFM25071\n\nMEPROBAMATE COMPONENT OF Q-GESIC\n\nMEPROBAMATE COMPONENT OF EQUAGESIC\n\nMEPROBAMATE COMPONENT OF MICRAININ\n\nNCGC00091031-02\n\nNCGC00257886-01\n\nMEPRO-ASPIRIN COMPONENT MEPROBAMATE\n\nSMR000058750\n\n2,2-DI(CARBAMOYLOXYMETHYL) PENTANE\n\nNS00004244\n\n2-methyl-2-propyl-1,3-propanediyldicarbamate\n\nD00376\n\n2-Methyl-2n-propyl-propane-1,3-dio-dicarbamate\n\nQ418351\n\nSR-01000937605\n\nSR-01000937605-2\n\nBRD-K19180152-001-02-6\n\nMeprobamate, United States Pharmacopeia (USP) Reference Standard\n\n2-Methyl-2-propyl-1,3-propanediol dicarbamate;NSC 30418;Pertranquil\n\n({2-[(C-hydroxycarbonimidoyloxy)methyl]-2-methylpentyl}oxy)carboximidic acid\n\n200-337-5\n\n3 Chemical and Physical Properties\n\n3.1 Computed Properties\n\nProperty Name\n\nProperty Value\n\nReference\n\nProperty Name\n\nMolecular Weight\n\nProperty Value\n\n218.25 g/mol\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2025.04.14)\n\nProperty Name\n\nXLogP3\n\nProperty Value\n\n0.7\n\nReference\n\nComputed by XLogP3 3.0 (PubChem release 2025.04.14)\n\n\n                    Context: \n                    This chunk lists additional identifiers, synonyms, and registry numbers for meprobamate, immediately preceding the section on chemical and physical properties. It serves as a bridge between the compound's various database entries (e.g., DrugBank ID, KEGG ID, WHO ATC code, Wikidata identifier) and the detailed computed physicochemical data that follows.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_10", "document_index": 50, "latency_s": 58.05665169999702, "prompt_toks": 28532, "completion_toks": 90}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    218.25 g/mol\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2025.04.14)\n\nProperty Name\n\nXLogP3\n\nProperty Value\n\n0.7\n\nReference\n\nComputed by XLogP3 3.0 (PubChem release 2025.04.14)\n\nProperty Name\n\nHydrogen Bond Donor Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)\n\nProperty Name\n\nHydrogen Bond Acceptor Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)\n\nProperty Name\n\nRotatable Bond Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)\n\nProperty Name\n\nExact Mass\n\nProperty Value\n\n218.12665706 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2025.04.14)\n\nProperty Name\n\nMonoisotopic Mass\n\nProperty Value\n\n218.12665706 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2025.04.14)\n\nProperty Name\n\nTopological Polar Surface Area\n\nProperty Value\n\n105 Å²\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)\n\nProperty Name\n\nHeavy Atom Count\n\n\n                    Context: \n                    This chunk presents computed molecular and physicochemical properties of meprobamate, such as molecular weight (218.25 g/mol), XLogP3 (0.7), exact and monoisotopic mass, and topological polar surface area, as calculated by various cheminformatics tools. It is part of the \"Chemical and Physical Properties\" section, offering key data for chemical characterization, screening, and reference in drug and compound databases.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_11", "document_index": 50, "latency_s": 53.511012700007996, "prompt_toks": 28459, "completion_toks": 78}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Property Name\n\nTopological Polar Surface Area\n\nProperty Value\n\n105 Å²\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)\n\nProperty Name\n\nHeavy Atom Count\n\nProperty Value\n\n15\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nFormal Charge\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nComplexity\n\nProperty Value\n\n212\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)\n\nProperty Name\n\nIsotope Atom Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Atom Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Atom Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCovalently-Bonded Unit Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\n\n                    Context: \n                    This chunk is part of the \"Computed Properties\" subsection under \"Chemical and Physical Properties\" for Meprobamate. It lists specific molecular descriptors such as topological polar surface area (105 Å²), heavy atom count (15), complexity, and other structural parameters, as calculated by computational chemistry tools in PubChem, providing detailed insights into the compound's physical and structural characteristics.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_12", "document_index": 50, "latency_s": 57.6694140000036, "prompt_toks": 28439, "completion_toks": 67}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Undefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCovalently-Bonded Unit Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCompound Is Canonicalized\n\nProperty Value\n\nYes\n\nReference\n\nComputed by PubChem (release 2025.04.14)\n\n3.2 Experimental Properties\n\n3.2.1 Physical Description\n\nMeprobamate appears as odorless white crystalline powder. Bitter taste. Solutions in water are neutral or slightly acidic. (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\nSolid\n\n3.2.2 Color / Form\n\nCrystals from hot water\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\nWhite powder\n\n\n                    Context: \n                    This section is part of the detailed chemical and physical properties of meprobamate, following computational property data and preceding solubility and melting point information. It provides experimental descriptions of meprobamate's appearance, physical state, and form—important for identifying the substance and distinguishing it from computationally derived properties elsewhere in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_13", "document_index": 50, "latency_s": 54.336961499997415, "prompt_toks": 28495, "completion_toks": 62}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Crystals from hot water\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\nWhite powder\n\nLewis, R.J. Sr.; Hawley's Condensed Chemical Dictionary 15th Edition. John Wiley & Sons, Inc. New York, NY 2007., p. 798\n\n3.2.3 Odor\n\nCharacteristic odor\n\nLewis, R.J. Sr.; Hawley's Condensed Chemical Dictionary 15th Edition. John Wiley & Sons, Inc. New York, NY 2007., p. 798\n\n3.2.4 Taste\n\nCharacteristic bitter taste\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\n3.2.5 Melting Point\n\n219 to 223 °F (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\n105 °C\n\nPhysProp\n\n105 °C\n\n\n                    Context: \n                    This excerpt appears within the \"Experimental Properties\" section of the \"Chemical and Physical Properties\" chapter, detailing the physical characteristics of meprobamate such as its appearance (crystals from hot water, white powder), odor, taste, and melting point, with references to authoritative chemical handbooks and databases.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_14", "document_index": 50, "latency_s": 54.974137500015786, "prompt_toks": 28530, "completion_toks": 70}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    105 °C\n\nPhysProp\n\n105 °C\n\nLide, D.R. CRC Handbook of Chemistry and Physics 88TH Edition 2007-2008. CRC Press, Taylor & Francis, Boca Raton, FL 2007, p. 3-372\n\n3.2.6 Solubility\n\nless than 1 mg/mL at 68 °F (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\n4700 mg/L (at 25 °C)\n\nYALKOWSKY,SH & DANNENFELSER,RM (1992)\n\nVery soluble in benzene, ethyl ether, ethanol\n\nLide, D.R. CRC Handbook of Chemistry and Physics 88TH Edition 2007-2008. CRC Press, Taylor & Francis, Boca Raton, FL 2007, p. 3-372\n\nEasily forms supersaturated solution with hot water; freely soluble in most org solvents\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\nSolubility in water: 0.34% (w/w) at 20 °C; 0.79% at 37 °C (w/w)\n\n\n                    Context: \n                    This chunk is from the \"Experimental Properties\" subsection under \"Chemical and Physical Properties\" of meprobamate, specifically detailing its melting point (105 °C) and solubility information in various solvents, including water, benzene, ethyl ether, ethanol, and hot water, with quantitative solubility values and references provided.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_15", "document_index": 50, "latency_s": 56.063051000004634, "prompt_toks": 28563, "completion_toks": 82}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Solubility in water: 0.34% (w/w) at 20 °C; 0.79% at 37 °C (w/w)\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\nSlightly sol in ether; sol in alcohol and acetone.\n\nLewis, R.J. Sr.; Hawley's Condensed Chemical Dictionary 15th Edition. John Wiley & Sons, Inc. New York, NY 2007., p. 798\n\nIn water, 3.3X10+3 mg/L at 25 °C\n\nYalkowsky, S.H., He, Yan., Handbook of Aqueous Solubility Data: An Extensive Compilation of Aqueous Solubility Data for Organic Compounds Extracted from the AQUASOL dATAbASE. CRC Press LLC, Boca Raton, FL. 2003., p. 610\n\n2.47e+00 g/L\n\n3.2.7 LogP\n\n0.7\n\nHANSCH,C ET AL. (1995)\n\nlog Kow = 0.70\n\nHansch, C., Leo, A., D. Hoekman. Exploring QSAR - Hydrophobic, Electronic, and Steric Constants. Washington, DC: American Chemical Society., 1995., p. 65\n\n0.7\n\n3.2.8 LogS\n\n1.67\n\nADME Research, USCD\n\n3.2.9 Stability / Shelf Life\n\n\n                    Context: \n                    This section presents detailed experimental data on Meprobamate's solubility in various solvents and temperatures, including quantitative water solubility at different temperatures and qualitative solubility in organic solvents. It is part of the broader \"Chemical and Physical Properties\" section, which provides comprehensive information on Meprobamate's physical characteristics, supporting identification, formulation, and safety assessment within the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_16", "document_index": 50, "latency_s": 56.93554999999469, "prompt_toks": 28583, "completion_toks": 102}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    0.7\n\n3.2.8 LogS\n\n1.67\n\nADME Research, USCD\n\n3.2.9 Stability / Shelf Life\n\nStable in dil acid and alkali and not broken down in gastric or intestinal juices.\n\nBudavari, S. (ed.). The Merck Index - Encyclopedia of Chemicals, Drugs and Biologicals. Rahway, NJ: Merck and Co., Inc., 1989., p. 921\n\n3.2.10 Decomposition\n\nWhen heated to decomp it emits toxic fumes of /nitrogen oxides./\n\nSax, N.I. Dangerous Properties of Industrial Materials. 6th ed. New York, NY: Van Nostrand Reinhold, 1984., p. 1948\n\n3.2.11 pH\n\nAqueous solutions are neutral\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\n3.2.12 Kovats Retention Index\n\nStandard non-polar\n\n1784 , 1762 , 1758 , 1762 , 1780 , 1785 , 1758 , 1764 , 1752 , 1762 , 1800 , 1800 , 1790 , 1771 , 1750 , 1758 , 1810 , 1810 , 1796 , 1785 , 1830 , 1785 , 1830 , 301.69 , 304.55\n\nSemi-standard non-polar\n\n1822.8 , 1826 , 1832 , 1802.5\n\n\n                    Context: \n                    This chunk is part of the \"Experimental Properties\" section detailing meprobamate's physicochemical characteristics. It provides data on logS (solubility parameter), stability in acidic/alkaline conditions, decomposition products (nitrogen oxides), pH of aqueous solutions, and Kovats retention indices under different chromatographic conditions. This information appears immediately after logP and solubility data, and before spectral information, serving to inform on the compound's stability, degradation, and analytical identification parameters.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_17", "document_index": 50, "latency_s": 55.66556950000813, "prompt_toks": 28500, "completion_toks": 112}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Semi-standard non-polar\n\n1822.8 , 1826 , 1832 , 1802.5\n\n3.3 SpringerMaterials Properties\n\nFusion temperature\n\nMelting temperature\n\nPhase transition\n\nTransition enthalpy\n\n3.4 Chemical Classes\n\nPharmaceutical\n\n3.4.1 Drugs\n\nPharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds\n\nS58 | PSYCHOCANNAB | Synthetic Cannabinoids and Psychoactive Compounds | DOI:10.5281/zenodo.3247723\n\nPharmaceuticals -> Hypnotics\n\nS57 | GREEKPHARMA | Suspect Pharmaceuticals from the National Organization of Medicine, Greece | DOI:10.5281/zenodo.3248883\n\nPharmaceuticals -> Listed in ZINC15\n\nS55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749\n\n3.4.1.1 Human Drugs\n\nBreast Feeding; Lactation; Milk, Human; Anti-Anxiety Agents; Hypnotics and Sedatives; Muscle Relaxants, Central\n\nHuman drug -> Discontinued\n\nHuman drug -> Prescription; Discontinued; Active ingredient (MEPROBAMATE)\n\n3.4.1.2 Animal Drugs\n\nPharmaceuticals -> Animal Drugs -> Approved in Taiwan\n\n\n                    Context: \n                    This section follows detailed experimental physicochemical data (e.g., Kovats retention index) and introduces property summaries from SpringerMaterials before transitioning into chemical classification. It classifies Meprobamate primarily as a pharmaceutical, lists its drug subcategories (such as synthetic cannabinoids/psychoactive compounds, hypnotics, entries in ZINC15), then specifies its status as a discontinued or prescription human drug (noting uses like anxiolytics, hypnotics, muscle relaxants, references to lactation), and mentions its approval as an animal drug in Taiwan.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_18", "document_index": 50, "latency_s": 55.970351500000106, "prompt_toks": 28555, "completion_toks": 92}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Human drug -> Discontinued\n\nHuman drug -> Prescription; Discontinued; Active ingredient (MEPROBAMATE)\n\n3.4.1.2 Animal Drugs\n\nPharmaceuticals -> Animal Drugs -> Approved in Taiwan\n\nS72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664\n\n4 Spectral Information\n\n4.1 1D NMR Spectra\n\n4.1.1 13C NMR Spectra\n\nCopyright\n\nCopyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.2 Mass Spectrometry\n\n4.2.1 GC-MS\n\n1 of 11\n\nView All\n\nSpectra ID\n\n27629\n\nInstrument Type\n\nEI-B\n\nIonization Mode\n\npositive\n\nSPLASH\n\nsplash10-053u-9100000000-d890d15ca6738ce72f60\n\nTop 5 Peaks\n\n83.0 99.99\n\n55.0 59.40\n\n71.0 44.90\n\n144.0 34.90\n\n62.0 30.40\n\nThumbnail\n\nThumbnail\n\nNotes\n\ninstrument=Unknown\n\n2 of 11\n\nView All\n\nMoNA ID\n\nJP003870\n\nMS Category\n\nExperimental\n\nMS Type\n\nGC-MS\n\nMS Level\n\nMS1\n\nInstrument\n\nUnknown\n\nInstrument Type\n\nEI-B\n\nIonization Mode\n\npositive\n\nTop 5 Peaks\n\n83 99.99\n\n55 59.40\n\n71 44.90\n\n\n                    Context: \n                    This section follows the discussion of meprobamate's classification as a discontinued human prescription drug. It introduces its status as an approved veterinary drug in Taiwan, then transitions into a new major section presenting detailed spectral information—including NMR and mass spectrometry (MS) data—with associated metadata for instrument type, ionization mode, spectral identifiers, and key fragment peaks. This situates analytical characterization data for meprobamate immediately after regulatory and usage classification details.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_19", "document_index": 50, "latency_s": 56.60979149999912, "prompt_toks": 28627, "completion_toks": 102}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    MoNA ID\n\nJP003870\n\nMS Category\n\nExperimental\n\nMS Type\n\nGC-MS\n\nMS Level\n\nMS1\n\nInstrument\n\nUnknown\n\nInstrument Type\n\nEI-B\n\nIonization Mode\n\npositive\n\nTop 5 Peaks\n\n83 99.99\n\n55 59.40\n\n71 44.90\n\n144 34.90\n\n62 30.40\n\nSPLASH\n\nsplash10-053u-9100000000-d890d15ca6738ce72f60\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-NC-SA\n\n4.2.2 MS-MS\n\n1 of 8\n\nView All\n\nSpectra ID\n\n2240819\n\nIonization Mode\n\nPositive\n\nSPLASH\n\nsplash10-052b-9100000000-353e329af17fdea1fe11\n\nTop 5 Peaks\n\n97.1017 100\n\n55.0545 63.56\n\n158.1178 24.32\n\n69.07 22.72\n\n115.1125 6.01\n\nThumbnail\n\nThumbnail\n\n2 of 8\n\nView All\n\nSpectra ID\n\n2247142\n\nIonization Mode\n\nPositive\n\nSPLASH\n\nsplash10-0a4i-9000000000-f351c8e0d2b10b45fdc9\n\nTop 5 Peaks\n\n55.0545 100\n\n62.0237 14.70\n\n53.0393 4.86\n\n69.0699 4.09\n\n59.0499 2.04\n\nThumbnail\n\nThumbnail\n\n4.2.3 LC-MS\n\n1 of 13\n\nView All\n\nAccession ID\n\nMSBNK-Univ_Connecticut-CO000261\n\nAuthors\n\nDennis W. Hill, Tzipporah M. Kertesz, Robert Friedman, David F. Grant\n\nInstrument\n\nMicromass Q-TOF II\n\nInstrument Type\n\nLC-ESI-QTOF\n\n\n                    Context: \n                    This chunk is from the \"Spectral Information\" section of the meprobamate compound page, specifically detailing experimental mass spectrometry data (MS, MS-MS, LC-MS) including MoNA and Spectra IDs, instrument types (e.g., GC-MS, EI-B, LC-ESI-QTOF), ionization modes, top fragment peaks, SPLASH identifiers, and associated licensing. This data supports analytical identification and characterization of meprobamate through its mass spectral signatures.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_20", "document_index": 50, "latency_s": 59.329945800011046, "prompt_toks": 28552, "completion_toks": 106}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    View All\n\nAccession ID\n\nMSBNK-Univ_Connecticut-CO000261\n\nAuthors\n\nDennis W. Hill, Tzipporah M. Kertesz, Robert Friedman, David F. Grant\n\nInstrument\n\nMicromass Q-TOF II\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n10 eV\n\nPrecursor m/z\n\n219.1346\n\nPrecursor Adduct\n\n[M+H]+\n\nTop 5 Peaks\n\n158.1167 999\n\n97.1018 155\n\n219.1333 53\n\n115.1127 13\n\nSPLASH\n\nsplash10-0a4i-1900000000-8dd8e00d9af9bce5cd26\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-SA\n\nReference\n\nMass Spectral Metabonomics beyond Elemental Formula: Chemical Database Querying by Matching Experimental with Computational Fragmentation Spectra, http://pubs.acs.org/doi/abs/10.1021/ac800548g\n\n2 of 13\n\nView All\n\nAccession ID\n\nMSBNK-Univ_Connecticut-CO000262\n\nAuthors\n\nDennis W. Hill, Tzipporah M. Kertesz, Robert Friedman, David F. Grant\n\nInstrument\n\nMicromass Q-TOF II\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n20 eV\n\n\n                    Context: \n                    This chunk is from the section detailing experimental mass spectrometry data for meprobamate, specifically under the LC-MS (liquid chromatography-mass spectrometry) subsection. It presents LC-ESI-QTOF MS/MS spectra (MS2 level) for meprobamate, including instrument details, collision energy, precursor m/z, major fragment ions (Top 5 Peaks), spectral identifiers, and literature reference. This information supports compound identification and analytical characterization within the comprehensive spectral information provided in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_21", "document_index": 50, "latency_s": 52.428869300027145, "prompt_toks": 28573, "completion_toks": 89}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Instrument\n\nMicromass Q-TOF II\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n20 eV\n\nPrecursor m/z\n\n219.1346\n\nPrecursor Adduct\n\n[M+H]+\n\nTop 5 Peaks\n\n97.1017 999\n\n55.0545 635\n\n158.1178 243\n\n69.07 227\n\n115.1125 60\n\nSPLASH\n\nsplash10-052b-9100000000-c21398e92cac7b48f567\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-SA\n\nReference\n\nMass Spectral Metabonomics beyond Elemental Formula: Chemical Database Querying by Matching Experimental with Computational Fragmentation Spectra, http://pubs.acs.org/doi/abs/10.1021/ac800548g\n\n4.2.4 Other MS\n\n1 of 2\n\nOther MS\n\nMASS: 27905 (NIST/EPA/MSDC Mass Spectral Database, 1990 version)\n\n2 of 2\n\nAccession ID\n\nMSBNK-Fac_Eng_Univ_Tokyo-JP003870\n\nAuthors\n\nSASAKI S, TOYOHASHI UNIV. OF TECH.\n\nInstrument\n\nUnknown\n\nInstrument Type\n\nEI-B\n\nMS Level\n\nMS\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nENERGY 70 eV\n\nTop 5 Peaks\n\n83 999\n\n55 594\n\n71 449\n\n144 349\n\n62 304\n\nSPLASH\n\nsplash10-053u-9100000000-d890d15ca6738ce72f60\n\n\n                    Context: \n                    This chunk presents specific mass spectrometry (MS) data for meprobamate, detailing experimental conditions (e.g., instrument type, ionization mode, collision energy), precursor and fragment ions, and spectral identifiers (SPLASH). It is part of the broader “Spectral Information” section, which provides analytical characterization data for meprobamate, supporting its identification and analysis within the overall chemical profile and reference data of the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_22", "document_index": 50, "latency_s": 61.252799399982905, "prompt_toks": 28515, "completion_toks": 110}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Instrument Type\n\nEI-B\n\nMS Level\n\nMS\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nENERGY 70 eV\n\nTop 5 Peaks\n\n83 999\n\n55 594\n\n71 449\n\n144 349\n\n62 304\n\nSPLASH\n\nsplash10-053u-9100000000-d890d15ca6738ce72f60\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-NC-SA\n\n4.3 IR Spectra\n\nIR Spectra\n\nIR: 5157 (Coblentz Society spectral collection)\n\n4.3.1 FTIR Spectra\n\nInstrument Name\n\nBio-Rad FTS\n\nTechnique\n\nKBr0\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nAlltech Associates, Inc., Grace Davison Discovery Sciences\n\nCatalog Number\n\n01708\n\nLot Number\n\n5210\n\nCopyright\n\nCopyright © 2012-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.3.2 ATR-IR Spectra\n\nInstrument Name\n\nBio-Rad FTS\n\nTechnique\n\nATR-Neat (DuraSamplIR II)\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nAlltech Associates, Inc., Grace Davison Discovery Sciences\n\nCatalog Number\n\n01708\n\nLot Number\n\n5210\n\nCopyright\n\nCopyright © 2009-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\n\n                    Context: \n                    This chunk appears within the \"Spectral Information\" section of the Meprobamate compound page and provides detailed analytical spectra data, specifically mass spectrometry (MS) and infrared (IR) spectra. It includes instrument type, ionization energy and mode, major MS fragment peaks, and licensing details for the spectral data, followed by information on FTIR and ATR-IR spectra such as instrument name, technique, sample source, catalog and lot numbers, and copyright. This section supports the chemical identification and analytical characterization of meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_23", "document_index": 50, "latency_s": 50.293866699998034, "prompt_toks": 28457, "completion_toks": 89}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Source of Sample\n\nAlltech Associates, Inc., Grace Davison Discovery Sciences\n\nCatalog Number\n\n01708\n\nLot Number\n\n5210\n\nCopyright\n\nCopyright © 2009-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.4 Raman Spectra\n\nTechnique\n\nFT-Raman\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nAlltech Associates, Inc., Grace Davison Discovery Sciences\n\nCatalog Number\n\n01708\n\nLot Number\n\n5210\n\nCopyright\n\nCopyright © 2012-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.5 Other Spectra\n\nIntense mass spectral peaks: 55 m/z, 83 m/z, 96 m/z, 114 m/z, 144 m/z\n\nPfleger, K., H. Maurer and A. Weber. Mass Spectral and GC Data of Drugs, Poisons and their Metabolites. Parts I and II. Mass Spectra Indexes. Weinheim, Federal Republic of Germany. 1985., p. 198\n\n5 Related Records\n\n5.1 Related Compounds with Annotation\n\n\n                    Context: \n                    This section appears within the \"Spectral Information\" part of the Meprobamate compound record, specifically detailing sources and technical information for Raman spectra and other spectrometric data. It immediately follows sections on IR spectra and precedes the \"Related Records\" segment, providing key experimental details such as technique (FT-Raman), sample origin, catalog and lot numbers, copyright holders, and notable mass spectral peaks for analytical identification and comparison purposes.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_24", "document_index": 50, "latency_s": 55.22752769998624, "prompt_toks": 28473, "completion_toks": 76}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    5 Related Records\n\n5.1 Related Compounds with Annotation\n\nFollow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see here for details), but these live search links provide equivalent functionality to the table that was previously shown here.\n\n5.2 Related Compounds\n\nSame Connectivity Count\n\nSame Parent, Connectivity Count\n\n16\n\nSame Parent, Exact Count\n\n11\n\nMixtures, Components, and Neutralized Forms Count\n\n35\n\nSimilar Compounds (2D)\n\nView in PubChem Search\n\nSimilar Conformers (3D)\n\nView in PubChem Search\n\n5.3 Substances\n\n5.3.1 PubChem Reference Collection SID\n\n483925871\n\n5.3.2 Related Substances\n\nAll Count\n\n205\n\nSame Count\n\n103\n\nMixture Count\n\n102\n\n5.3.3 Substances by Category\n\n5.4 Other Relationships\n\nAspirin; meprobamate (component of)\n\nEstrogens, conjugated; meprobamate (component of)\n\n5.5 Entrez Crosslinks\n\nPubMed Count\n\n657\n\nTaxonomy Count\n\nOMIM Count\n\nGene Count\n\n17\n\n5.6 NCBI LinkOut\n\n\n                    Context: \n                    This section provides information on compounds and substances related to meprobamate, including structurally similar compounds, mixtures, components, and neutralized forms. It includes reference identifiers, counts of related substances in various categories, and links to associated records such as PubMed articles, genes, and other databases, helping users explore chemical relationships and cross-references within PubChem and external resources.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_25", "document_index": 50, "latency_s": 56.15507599999546, "prompt_toks": 28464, "completion_toks": 70}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Aspirin; meprobamate (component of)\n\nEstrogens, conjugated; meprobamate (component of)\n\n5.5 Entrez Crosslinks\n\nPubMed Count\n\n657\n\nTaxonomy Count\n\nOMIM Count\n\nGene Count\n\n17\n\n5.6 NCBI LinkOut\n\n6 Chemical Vendors\n\n7 Drug and Medication Information\n\n7.1 Drug Indication\n\nFor the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.\n\n7.2 LiverTox Summary\n\nMeprobamate is a sedative used for anxiety and insomnia first made available in the 1950s when it became very popular, but which is now rarely used. Meprobamate therapy was not associated with liver enzyme elevations and has not been linked to instances of clinically apparent liver injury.\n\n7.3 Drug Classes\n\nBreast Feeding; Lactation; Milk, Human; Anti-Anxiety Agents; Hypnotics and Sedatives; Muscle Relaxants, Central\n\nSedatives and Hypnotics\n\n7.4 FDA Approved Drugs\n\n7.5 FDA Orange Book\n\n7.6 FDA National Drug Code Directory\n\n7.7 Drug Labels\n\nDrug and label\n\nActive ingredient and drug\n\n\n                    Context: \n                    This section details related compounds containing meprobamate, references to scientific databases and crosslinks, and transitions into comprehensive drug and medication information. It includes meprobamate's clinical indications, summary of liver safety, pharmacological classes, and links to regulatory databases and labeling, thereby bridging related substance data with therapeutic, regulatory, and safety information.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_26", "document_index": 50, "latency_s": 56.567017499997746, "prompt_toks": 28469, "completion_toks": 87}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Sedatives and Hypnotics\n\n7.4 FDA Approved Drugs\n\n7.5 FDA Orange Book\n\n7.6 FDA National Drug Code Directory\n\n7.7 Drug Labels\n\nDrug and label\n\nActive ingredient and drug\n\n7.8 DEA Drug and Chemical Information\n\n7.8.1 DEA Controlled Substances\n\n1 of 2\n\nSubstance\n\nMeprobamate\n\nDEA Controlled Substances Code Number\n\n2820\n\nControlled Substances Act Schedule\n\nSchedule IV - Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.\n\nClass\n\nDepressants\n\n2 of 2\n\nNon-Proprietary Name\n\nMEPROBAMATE\n\nDEA Substances Act Schedule\n\nSchedule IV\n\n7.9 Therapeutic Uses\n\nAnti-Anxiety Agents; Anticonvulsants; Muscle Relaxants, Central; Sedatives, Nonbarbiturate\n\nNational Library of Medicine's Medical Subject Headings online file (MeSH, 1999)\n\nMedication (Vet): ... /Used occasionally/ as sedative with little or no tranquilization in many species.\n\nRossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 337\n\n\n                    Context: \n                    This section details regulatory, classification, and therapeutic information about meprobamate, including its status as a Schedule IV controlled substance under DEA regulations, its inclusion in drug directories and labels, and its uses as a sedative, anxiolytic, anticonvulsant, and muscle relaxant for humans and animals. It provides official identifiers and highlights its categorization among depressant drugs with low abuse potential relative to higher schedules.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_27", "document_index": 50, "latency_s": 56.40363879999495, "prompt_toks": 28423, "completion_toks": 102}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 337\n\nMeprobamate has been used preoperatively to relieve anxiety and provide sedation. Meprobamate is effective in promoting sleep in the anxious, tense patient. There is no convincing evidence that meprobamate has any advantage over other sedatives, including barbiturates, in relieving anxiety and tension. /Included in US product label/\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nMeprobamate in fixed combination with aspirin is used as an adjunct in the short-term (<10 days) treatment of pain accompanied by tension and/or anxiety in patients with musculoskeletal disease. The combination has been shown to be more effective than aspirin alone. /Included in US product label/\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n\n                    Context: \n                    This chunk appears in the section summarizing the therapeutic uses of meprobamate, specifically highlighting its role in preoperative sedation, management of anxiety, and as a component in combination therapy with aspirin for musculoskeletal pain and tension. It emphasizes that while meprobamate is effective for these indications, clinical evidence does not show superiority over other sedatives, such as barbiturates. This is part of the broader drug and medication information section detailing approved indications, formulations, and clinical effectiveness.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_28", "document_index": 50, "latency_s": 54.20332829997642, "prompt_toks": 28400, "completion_toks": 75}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nMeprobamate is used for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The efficacy of meprobamate for long-term use (i.e., longer than 4 months) has not been evaluated; the need for continued therapy should be reassessed periodically. Meprobamate may be useful as an adjunct when anxiety complicates psychosis or the treatment of alcohol dependence. However, the additive CNS depressant effects of meprobamate and alcohol should be considered. /Included in US product label/\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n7.10 Drug Warnings\n\n\n                    Context: \n                    This section details the therapeutic uses of meprobamate, specifically its indication for managing anxiety disorders and short-term relief of anxiety symptoms, while noting its limited evaluation for long-term use and considerations for use alongside other conditions such as psychosis or alcohol dependence. It immediately precedes the \"Drug Warnings\" section and is part of the broader drug and medication information within the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_29", "document_index": 50, "latency_s": 56.80503009998938, "prompt_toks": 28462, "completion_toks": 90}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n7.10 Drug Warnings\n\nMeprobamate frequently produces drowsiness. Other effects include nausea, vomiting, diarrhea, paresthesia, weakness, and CNS effects such as headache, paradoxical excitement, dizziness, ataxia, and disturbances of vision. There may be hypotensin, tachycardia, and cardiac dysrhythmias. Hypersensitivity reactions occur occasionally. These may be limited to skin rashes, urticaria, and purpura or may be more severe with angioedema, bronchospasm, or anuria. Erythema multiforme or Stevens-Johnson syndrome and exfoliative or bullous dermatitis have been reported. Blood disorders, including agranulocytosis, eosinophilia, leukopenia, thrombocytopenia, and aplastic anemia, have occasionally been reported.\n\nDart, R.C. (ed). Medical Toxicology. Third Edition, Lippincott Williams & Wilkins. Philadelphia, PA. 2004., p. 893-4\n\n\n                    Context: \n                    This chunk is from the \"Drug Warnings\" section within the broader drug and medication information portion of the Meprobamate compound page. It details the adverse effects, hypersensitivity reactions, and rare but serious side effects associated with meprobamate use, providing important safety information for clinicians and patients. This content is part of a comprehensive reference framework that includes pharmacology, clinical uses, regulatory status, and toxicity information for meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_30", "document_index": 50, "latency_s": 54.318641499994555, "prompt_toks": 28387, "completion_toks": 83}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Dart, R.C. (ed). Medical Toxicology. Third Edition, Lippincott Williams & Wilkins. Philadelphia, PA. 2004., p. 893-4\n\nClinical studies of meprobamate (with or without aspirin) did not include sufficient numbers of patients 65 years of age and older to determine whether geriatric patients respond differently than younger patients. While other clinical experience has not revealed age-related differences in response, drug dosage generally should be titrated carefully in geriatric patients, usually initiating therapy at the low end of the dosage range. The greater frequency of decreased hepatic, renal, and/or cardiac function and of concomitant disease and drug therapy observed in the elderly also should be considered.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n\n                    Context: \n                    This chunk is part of the \"Drug Warnings\" section of the Meprobamate page, discussing considerations for meprobamate use in elderly patients. It highlights the lack of sufficient clinical data for patients 65 years and older, and recommends cautious dosing in geriatric populations due to possible decreased organ function and increased comorbidities, aligning with general safety guidance for medication administration in older adults.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_31", "document_index": 50, "latency_s": 59.032841199979885, "prompt_toks": 28306, "completion_toks": 90}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nWhen meprobamate is used in fixed combination with aspirin, the usual cautions, precautions, and contraindications associated with aspirin must be considered in addition to those associated with meprobamate.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n\n                    Context: \n                    This excerpt is from the Drug Warnings section, specifically addressing safety and precautionary considerations when meprobamate is administered in combination with aspirin. It emphasizes that, in addition to meprobamate's own precautions, the standard warnings and contraindications for aspirin must also be taken into account. This guidance is part of the broader discussion on therapeutic use, side effects, and risk management for meprobamate and its combinations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_32", "document_index": 50, "latency_s": 55.86245909999707, "prompt_toks": 28429, "completion_toks": 108}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nSeveral studies have suggested and increased risk of congenital malformations associated with the use of anxiolytics (meprobamate, chlordiazepoxide, diazepam) during the first trimester of pregnancy. Since the use of anxiolytics is rarely urgent, their use during the first trimester should almost always be avoided. The possiblity that a woman of childbearing potential may be pregnant at the time therapy is initiated should be considered. Patients should be advised that if they become pregnant or intend to become pregnant during therapy, they should communicate with their physician about the desirability of discontinuing the drug.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nFor more Drug Warnings (Complete) data for MEPROBAMATE (24 total), please visit the HSDB record page.\n\n7.11 Drug Idiosyncrasies\n\n\n                    Context: \n                    This excerpt is from the \"Drug Warnings\" section of the Meprobamate compound page, detailing safety information related to the use of meprobamate during pregnancy. It highlights studies suggesting an increased risk of congenital malformations with anxiolytic use (including meprobamate) in the first trimester, recommends avoiding these drugs early in pregnancy, and advises consultation with a physician if pregnancy occurs during therapy. This section is part of broader safety, toxicity, and clinical guidance information provided for meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_33", "document_index": 50, "latency_s": 52.56202039998607, "prompt_toks": 28428, "completion_toks": 100}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    For more Drug Warnings (Complete) data for MEPROBAMATE (24 total), please visit the HSDB record page.\n\n7.11 Drug Idiosyncrasies\n\nMild to severe allergic or idiosyncratic reaction may occur, particularly in patients with a history of dermatologic or allergic conditions. In patients who have not received meprobamate previously, these reactions are usually evident by the time of the fourth dose of the drug. Mild reactions are characterized by pruritus, urticaria, and/or erythematous maculopapular rash which may be generalized or confined to the groin area. Other idiosyncratic reactions have included leukenia, acute nonthrombocytopenic purpura, petechiae, ecchymoses, eosinophilia, adenopathy, peripheral edema, fever, and fixed drug eruptions with a cross-reaction to carisprodol. Cross-sensitivity between merobamate and mebutamate and/or carbromal has also occurred.\n\n\n                    Context: \n                    This section provides information on drug idiosyncrasies associated with meprobamate, following general drug warnings in the document. It details the range and characteristics of rare allergic or unpredictable hypersensitivity reactions to meprobamate, such as skin rashes and blood abnormalities, and notes the potential for cross-sensitivity with related compounds. This content is part of the broader safety and toxicity information presented for meprobamate, which includes adverse effects, warnings, dependence, and contraindications.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_34", "document_index": 50, "latency_s": 55.641508200002136, "prompt_toks": 28383, "completion_toks": 72}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1992 (Plus Supplements 1992)., p. 1370\n\n7.12 Drug Tolerance\n\nTolerance and psychologic and physical dependence may occur following prolonged use of high doses of meprobamate. Daily ingestion of 3.2 g of meprobamate for weeks or months has produced physical dependence and withdrawal symptoms when the drug was suddenly discontinued. Because of the drug's potential for inducing dependence, prolonged administration of meprobamate is not recommended.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n8 Pharmacology and Biochemistry\n\n8.1 Pharmacodynamics\n\n\n                    Context: \n                    This section discusses meprobamate’s potential for drug tolerance and dependence with prolonged high-dose use, noting withdrawal risks and discouraging long-term administration. It appears in the comprehensive drug information portion of the document, specifically preceding the detailed pharmacology and biochemistry section that follows the overall clinical uses, indications, and drug safety warnings for meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_35", "document_index": 50, "latency_s": 55.82249399999273, "prompt_toks": 28440, "completion_toks": 86}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n8 Pharmacology and Biochemistry\n\n8.1 Pharmacodynamics\n\nMeprobamate is an anxiolytic drug. It was the best selling minor tranquilizer for a time but has largely been replaced by benzodiazepines. Meprobamate has most of the pharmacological effects and dangers of the barbiturates (though it was marketed as being safer) but it is less sedating at effective doses. Meprobamate exhibits some anticonvulsant effects in absence seizures; however, it is reported to potentially exacerbate generalized tonic-clonic seizures. It has also been used as a hypnotic (sleeping pill). However, its is currently only licensed as an anxiolytic and it is a third or fourth-order choice.\n\n8.2 MeSH Pharmacological Classification\n\nHypnotics and Sedatives\n\nDrugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)\n\n\n                    Context: \n                    This section is from the comprehensive \"Pharmacology and Biochemistry\" part of the meprobamate compound profile, following extensive chemical property data, safety, and drug information. It details meprobamate's pharmacodynamics, therapeutic classification, and clinical use as an anxiolytic and sedative, situating the drug within broader pharmacological categories after discussions of its molecular characteristics, formulations, regulatory status, and toxicity.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_36", "document_index": 50, "latency_s": 54.88562130002538, "prompt_toks": 28369, "completion_toks": 64}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Hypnotics and Sedatives\n\nDrugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)\n\nAnti-Anxiety Agents\n\nAgents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)\n\nAnticonvulsants\n\nDrugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)\n\nMuscle Relaxants, Central\n\n\n                    Context: \n                    This chunk lists the MeSH pharmacological classifications of meprobamate, describing its roles as a hypnotic and sedative, anti-anxiety agent, anticonvulsant, and central muscle relaxant. It is part of the broader pharmacology and biochemistry section, providing standardized therapeutic categories for the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_37", "document_index": 50, "latency_s": 57.381829399993876, "prompt_toks": 28457, "completion_toks": 72}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Anticonvulsants\n\nDrugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)\n\nMuscle Relaxants, Central\n\nA heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)\n\n8.3 ATC Code\n\nN - Nervous system\n\nN05 - Psycholeptics\n\nN05B - Anxiolytics\n\nN05BC - Carbamates\n\nN05BC01 - Meprobamate\n\n8.4 Absorption, Distribution and Excretion\n\nAbsorption\n\n\n                    Context: \n                    This section is part of the \"Pharmacology and Biochemistry\" chapter, detailing meprobamate’s pharmacological classifications—including as an anticonvulsant and central muscle relaxant—and listing its Anatomical Therapeutic Chemical (ATC) code, followed by an introduction to its pharmacokinetics (absorption, distribution, and excretion).\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_38", "document_index": 50, "latency_s": 59.24685429999954, "prompt_toks": 28491, "completion_toks": 104}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    8.3 ATC Code\n\nN - Nervous system\n\nN05 - Psycholeptics\n\nN05B - Anxiolytics\n\nN05BC - Carbamates\n\nN05BC01 - Meprobamate\n\n8.4 Absorption, Distribution and Excretion\n\nAbsorption\n\nWell absorbed from the gastrointestinal tract.\n\nThe concentrations of meprobamate in the blood and liver were determined in 12 cases of death due to meprobamate poisoning and in 29 cases of death due to the combined effects of meprobamate and alcohol, meprobamate and barbiturate, or meprobamate, alcohol and barbiturate. In the cases of poisoning from meprobamate alone, the blood meprobamate concentrations were within the range of 142-342 ug/mL. (mean value, 226 ug./mL). In the cases of poisoning with a combination of the drugs, the blood meprobamate concentrations were: for meprobamate and alcohol, 43-155 ug/mL (mean value, 117 ug/mL); for meprobamate and barbiturate, 30-276 ug/mL (mean value, 117 ug/mL); for meprobamate, barbiturate and alcohol, 33-460 ug/mL (mean value, 133 ug/mL).\n\n\n                    Context: \n                    This passage is from the pharmacology and biochemistry section of the Meprobamate compound profile. It provides the ATC (Anatomical Therapeutic Chemical) classification for meprobamate and details its absorption, distribution, and excretion characteristics, including specific blood concentration data observed in cases of poisoning and combined drug use. This contextual information supports understanding of the drug’s pharmacokinetics and clinical toxicology within the broader chemical, safety, regulatory, and therapeutic overview of meprobamate presented in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_39", "document_index": 50, "latency_s": 52.42547499999637, "prompt_toks": 28476, "completion_toks": 81}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Felby S; Acta Pharmacol. Toxicol 28 (5): 334-7 (1970)\n\nProfound meprobamate intoxication is associated with plasma levels of 20 mg/100mL. Most pt appear to be comatose at levels about 10 mg/100 mL, whereas consciousness occurs at levels below 5 mg/100 mL.\n\nGosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. III-260\n\nThe effect of hemoperfusion based on pharmacokinetic parameters in 4 cases of severe meprobamate intoxication is described. Maximal plasma levels reached 800, 816, 963 and 923 umol/L. All patients survived without sequelae including one patient resuscitated from cardiac arrest. The amount of meprobamate removed by hemoperfusion ranged from 1.6-6.2 g. Results suggest that hemoperfusion may be indicated in severe meprobamate intoxication.\n\nPMID:3669117\n\nJacobsen D et al; J Toxicol Clin Toxicol 25 (4): 317-31 (1987)\n\n\n                    Context: \n                    This chunk appears within the \"Absorption, Distribution and Excretion\" section of Meprobamate's pharmacology, providing clinical data on plasma concentrations associated with intoxication, coma, and consciousness, as well as outcomes and treatment via hemoperfusion in severe poisoning cases. It contextualizes toxic plasma levels and underscores the role of hemoperfusion as a potential therapeutic intervention for meprobamate overdose.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_40", "document_index": 50, "latency_s": 54.958861799997976, "prompt_toks": 28444, "completion_toks": 62}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:3669117\n\nJacobsen D et al; J Toxicol Clin Toxicol 25 (4): 317-31 (1987)\n\nMeprobamate is well absorbed from the GI tract following oral administration. Plasma concentrations of meprobamate required for sedative or hypnotic effects are not known. Oral administration of 400 mg of meprobamate produces peak plasma concentrations of 5-39 ug/mL within 1-3 hr. Plasma concentrations of 30-100 ug/mL are usually reached following mild overdosage and are associated with stupor or light coma. Plasma concentrations of 100-200 ug/mL are associated with deep coma and are potentially lethal; fatalities frequently occur when plasma concentrations exceed 200 ug/mL. The onset of sedative action is usually less than 1 hour following oral administration of meprobamate.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nFor more Absorption, Distribution and Excretion (Complete) data for MEPROBAMATE (6 total), please visit the HSDB record page.\n\n\n                    Context: \n                    This chunk is from the \"Absorption, Distribution and Excretion\" subsection under \"Pharmacology and Biochemistry,\" providing clinical details on meprobamate’s oral absorption, typical plasma concentrations after dosing, onset of action, and concentration ranges associated with therapeutic effect, overdose, coma, and fatalities.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_41", "document_index": 50, "latency_s": 54.89247630001046, "prompt_toks": 28436, "completion_toks": 71}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    For more Absorption, Distribution and Excretion (Complete) data for MEPROBAMATE (6 total), please visit the HSDB record page.\n\n8.5 Metabolism / Metabolites\n\nMeprobamate undergoes hepatic metabolism.\n\nMeprobamate is rapidly metabolized in the liver. Meprobamate can induce liver microsomal enzymes and thus may at least theoretically alter the metabolism of other drugs such as warfarin. There is some evidence that meprobamate may accelerate its own metabolism. Meprobamate metabolites are inactive and include 2B-hydroxymeprobamate, and glucosyluronide and glucuronide conjugates of meprobamate. These metabolites are excreted by the kidneys. About 10-12% of a dose of meprobamate is excreted in urine as unchanged drug within 24 hr. The remainder is excreted in urine as metabolites.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n\n                    Context: \n                    This section is part of the pharmacology and biochemistry content for meprobamate, specifically describing its metabolism and metabolites following absorption and distribution. It details hepatic metabolism, enzyme induction, identified inactive metabolites, and excretion patterns, providing key information relevant for understanding meprobamate’s pharmacokinetics and implications for drug interactions and elimination.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_42", "document_index": 50, "latency_s": 56.773521600000095, "prompt_toks": 28472, "completion_toks": 95}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nMost of the drug is metabolized in the liver, mainly to a side-chain hydroxy derivative and a glucuronide; the kinetics of elimination may depend on the dose.\n\nHardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill, 2006., p. 422\n\nA whole-body exposure of rats to 8 Gy radiation is ineffective in 3 days, and in 6 days, it prolongs considerably the effect and increases the pharmacological activity of hexenal, meprobamate, ethylmorphine, and amidopyrine, inhibits the activity of amidopyrine demethylase, aniline hydroxylase, NADPH-cytochrome c reductase, and reduces the content of protein, cytochromes P-450 and b5 in a microsomal liver fraction.\n\nPMID:2780982\n\nKhakimov ZZ; Radiobiologiia 29 (4): 492-4 (1989)\n\n\n                    Context: \n                    This chunk is from the \"Pharmacology and Biochemistry\" section, specifically under \"Metabolism / Metabolites\" of meprobamate. It details meprobamate's hepatic metabolism to hydroxy and glucuronide derivatives, notes that elimination kinetics may be dose-dependent, and includes an animal study showing that radiation affects liver enzymes and drug metabolism, emphasizing the role of liver function and external factors on meprobamate's biotransformation.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_43", "document_index": 50, "latency_s": 56.22174549999181, "prompt_toks": 28479, "completion_toks": 91}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Carisoprodol is metabolized to meprobamate by the cytochrome P450 enzyme CYP2C19, encoded by the polymorphic CYP2C19 gene. Most studies on carisoprodol metabolism have been carried out on individuals phenotyped for CYP2C19 activity using the probe drug S-mephenytoin. /The investigators/ aimed to investigate whether the ratio of carisoprodol to meprobamate in a 'real life' setting could be predicted by CYP2C19 genotype or, more specifically, if high carisoprodol : meprobamate ratios in drugged drivers could be ascribed to the presence of mutant CYP2C19 alleles. From original material comprising 358 blood samples from apprehended drivers, two polarized groups were selected; a high-ratio group of 11 subjects where the carisoprodol : meprobamate ratio was >1 and a low-ratio control group of 23 subjects where the ratio was <0.31. Genotyping was carried out for the CYP2C19*2, CYP2C19*3 and CYP2C19*4 alleles. DNA samples from 94 healthy blood donors were used as reference material. The\n\n\n                    Context: \n                    This passage appears in the section discussing the metabolism of meprobamate within the broader pharmacology and biochemistry content. Specifically, it details how carisoprodol is metabolized to meprobamate by the liver enzyme CYP2C19, and examines the influence of CYP2C19 genetic polymorphisms on this metabolic conversion, based on a study analyzing blood samples and genotypes in carisoprodol-exposed individuals.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_44", "document_index": 50, "latency_s": 55.33557289998862, "prompt_toks": 28456, "completion_toks": 86}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    of 23 subjects where the ratio was <0.31. Genotyping was carried out for the CYP2C19*2, CYP2C19*3 and CYP2C19*4 alleles. DNA samples from 94 healthy blood donors were used as reference material. The number of mutant alleles in the high-ratio and low-ratio groups was significantly higher and lower, respectively, than in the reference material. The increased number of mutant alleles in the high-ratio group was not due to the presence of many poor metabolizers, but to a high number of heterozygous individuals with the genotype CYP2C19*1/*2. This result indicates a gene dosage effect where the carisoprodol : meprobamate ratio reflects the number of active CYP2C19 alleles. The metabolism of carisoprodol to meprobamate is dependent on CYP2C19 genotype. Heterozygous individuals with the CYP2C19*1/*2 genotype have a reduced capacity for metabolizing carisoprodol, and should probably be regarded as intermediate metabolizers of this drug. /Carisoprodol/\n\n\n                    Context: \n                    This passage is from the section discussing the metabolism of meprobamate and its precursor carisoprodol, specifically addressing the role of CYP2C19 genetic variants in determining the conversion rate of carisoprodol to meprobamate. It highlights pharmacogenetic differences affecting drug metabolism, detailing how CYP2C19 genotype influences metabolizer status and, consequently, meprobamate exposure in individuals.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_45", "document_index": 50, "latency_s": 58.545258800004376, "prompt_toks": 28473, "completion_toks": 103}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:12835613\n\nBramness JG et al; Pharmacogenetics 13 (7): 383-8 (2003).\n\n8.6 Biological Half-Life\n\nPlasma half-life is about 10 hours.\n\nThe plasma half-life of meprobamate averages about 10-11 hours but may range from 6-16 hours.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n6-17 hours /From table/\n\nHardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill, 2006., p. 421\n\n8.7 Mechanism of Action\n\nMeprobamate's mechanism of action is not fully understood; in animal studies, meprobamate is reported to act at multiple sites in the central nervous system, such as the thalamus and limbic system. It binds to the GABAA receptors, leading to inhibitory effects on the neurons transmitting signals in the reticular formation and spinal cord. Consequently, effects such as sedation and altered perception of pain are observed.\n\n\n                    Context: \n                    This chunk appears within the \"Pharmacology and Biochemistry\" section of the meprobamate compound page, specifically under the subsections discussing the drug's biological half-life and its mechanism of action. It provides information about meprobamate’s average plasma half-life (typically 10-11 hours) and details on its CNS depressant activity, including proposed actions at GABAA receptors and resulting sedative effects. This content is relevant for understanding meprobamate’s pharmacokinetics and pharmacodynamics.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_46", "document_index": 50, "latency_s": 55.078238099988084, "prompt_toks": 28419, "completion_toks": 81}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprobamate has CNS depressant actions similar to those of the barbiturates. The mechanism of action of meprobamate is not known. The drug apparently acts at multiple sites in the CNS including the hypothalamus, thalamus, limbic system, and spinal cord, but not the medulla, the reticular activating system, or in the autonomic nervous system. Although there is some evidence that meprobamate relaxes skeletal muscle tension, the skeletal muscle relaxant effects of the drug are probably caused by its sedative effect.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nThe potentiation of the release of adenosine by meprobamate may account for its central effects.\n\nUllmann's Encyclopedia of Industrial Chemistry. 6th ed.Vol 1: Federal Republic of Germany: Wiley-VCH Verlag GmbH & Co. 2003 to Present, p. V30 433\n\n\n                    Context: \n                    This excerpt is from the \"Mechanism of Action\" section within the pharmacology and biochemistry part of the Meprobamate compound page. It discusses the drug’s CNS depressant effects, its similarities and differences compared to barbiturates, probable sites of action in the central nervous system, potential mechanisms involving adenosine release, and the relation of its muscle relaxant properties to sedation.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_47", "document_index": 50, "latency_s": 53.58798670000397, "prompt_toks": 28445, "completion_toks": 87}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Ullmann's Encyclopedia of Industrial Chemistry. 6th ed.Vol 1: Federal Republic of Germany: Wiley-VCH Verlag GmbH & Co. 2003 to Present, p. V30 433\n\nIn animals, meprobamate antagonizes the convulsant effects of pentylenetetrazol, but meprobamate is of no clinical use for the management of epilepsy; in fact, the drug may aggravate generalized tonic-clonic (grand mal) seizures. Usual sedative doses of meprobamate have little or no effect on the EEG, but 800-mg doses produce increased fast activity, increased amplitude, and prominent beta waves. Like barbiturates, hypnotic doses of meprobamate substantially suppress rapid eye movement (REM) or dreaming stage of sleep. REM rebound has been reported to occur when the drug was withdrawn and thus could cause the patient to experience markedly increased dreaming, nightmares, and/or insomnia.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n8.8 Human Metabolite Information\n\n\n                    Context: \n                    This passage appears within the \"Pharmacology and Biochemistry\" section of the meprobamate compound entry. It describes specific pharmacodynamic effects of meprobamate on the central nervous system, including its impact on seizure activity, EEG patterns, sleep architecture, and withdrawal phenomena. This information helps clarify the drug's CNS actions, clinical limitations, and withdrawal effects, supporting understanding of its therapeutic profile and risks compared to similar agents.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_48", "document_index": 50, "latency_s": 55.61801599999308, "prompt_toks": 28479, "completion_toks": 73}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n8.8 Human Metabolite Information\n\n8.8.1 Cellular Locations\n\nMembrane\n\n8.8.2 Metabolite Pathways\n\nCapecitabine Action Pathway\n\nCapecitabine Metabolism Pathway\n\n8.9 Biochemical Reactions\n\n8.10 Transformations\n\n9 Use and Manufacturing\n\n9.1 Uses\n\nMedicine (antianxiety agent)\n\nLewis, R.J. Sr.; Hawley's Condensed Chemical Dictionary 15th Edition. John Wiley & Sons, Inc. New York, NY 2007., p. 798\n\nTHERAP CAT: Anxiolytic\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\nMeprobamate is rapidly absorbed after oral administration and has a duration of 3 - 4 hr. Its primary clinical use is for daytime sedation in anxious patients, but it is occasionally administered orally as part of a regimen of bedrest and physical rehabilitation for painful musculoskeletal conditions.\n\n\n                    Context: \n                    This chunk appears within the document’s pharmacology section immediately after discussion of meprobamate's human metabolism and metabolites, specifically its cellular locations and pathways. It introduces the subsequent section on the compound’s uses and manufacturing, beginning with recognized medical uses, therapeutic categories (such as anxiolytic), and context on its clinical application for anxiety and sedation.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_49", "document_index": 50, "latency_s": 55.45843930001138, "prompt_toks": 28443, "completion_toks": 85}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Ullmann's Encyclopedia of Industrial Chemistry. 6th ed.Vol 1: Federal Republic of Germany: Wiley-VCH Verlag GmbH & Co. 2003 to Present, p. V33 90\n\nMeprobamate is an anxiolytic agent which has anticonvulsant, myorelaxant, and sedative properties, but it does not directly interfere with the GABA-receptor complex ... This carbamate derivative has been used for the management of anxiety disorders and tension states but has been superseded by benzodiazepines.\n\nUllmann's Encyclopedia of Industrial Chemistry. 6th ed.Vol 1: Federal Republic of Germany: Wiley-VCH Verlag GmbH & Co. 2003 to Present, p. V30 433\n\nFor more Uses (Complete) data for MEPROBAMATE (6 total), please visit the HSDB record page.\n\n9.1.1 Use Classification\n\nHuman Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients\n\nPharmaceuticals -> Animal Drugs -> Approved in Taiwan\n\n\n                    Context: \n                    This chunk appears in the \"Uses\" section of the Meprobamate compound page, summarizing its pharmacological properties—anxiolytic, anticonvulsant, myorelaxant, and sedative—and noting its historical role in treating anxiety disorders before being largely replaced by benzodiazepines. It highlights key sources and is directly followed by classifications of meprobamate in regulatory and pharmaceutical contexts.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_50", "document_index": 50, "latency_s": 58.784917999990284, "prompt_toks": 28454, "completion_toks": 65}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients\n\nPharmaceuticals -> Animal Drugs -> Approved in Taiwan\n\nS72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664\n\n9.2 Methods of Manufacturing\n\n/Meprobamate is/ prepared by reaction of 2-methyl-2-propyl-1,3-propanediol with excess phosgene and ammonium hydroxide.\n\nUllmann's Encyclopedia of Industrial Chemistry. 6th ed.Vol 1: Federal Republic of Germany: Wiley-VCH Verlag GmbH & Co. 2003 to Present, p. V33 90 (2003)\n\nPreparation: ... Berger, Ludwig, US 2724720 (1955 to Carter Prod.)\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\n9.3 Formulations / Preparations\n\n\n                    Context: \n                    This section appears within the \"Use and Manufacturing\" part of the meprobamate compound profile, specifically detailing its human and animal drug approval status, as well as describing the chemical synthesis methods used to manufacture meprobamate. It follows a list of therapeutic use classifications and precedes information about available drug formulations and preparations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_51", "document_index": 50, "latency_s": 52.91847669999697, "prompt_toks": 28476, "completion_toks": 104}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\n9.3 Formulations / Preparations\n\nOral: Tablets 200 mg Meprobamate Tablets (Watson); 400 mg Meprobamate Tablets (Watson). NOTE: Available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nOral: Tablets: 200 mg with Aspirin 325 mg, Equagesic (C-IV; scored) (Leitner). /Meprobamate combinations/\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n9.4 General Manufacturing Information\n\nEPA TSCA Commercial Activity Status\n\n1,3-Propanediol, 2-methyl-2-propyl-, 1,3-dicarbamate: ACTIVE\n\nThis is a controlled substance (depressant): 21CFR1308.14\n\n\n                    Context: \n                    This section appears in the \"Use and Manufacturing\" part of the document, specifically under \"Formulations / Preparations\" and \"General Manufacturing Information\" for meprobamate. It provides details on available oral tablet dosages, including meprobamate-only and combination products with aspirin, mentions product availability under generic and brand names, and notes regulatory status (EPA TSCA activity and controlled substance scheduling). This context relates to practical manufacturing, preparation, and marketing of meprobamate pharmaceuticals.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_52", "document_index": 50, "latency_s": 54.80771409999579, "prompt_toks": 28444, "completion_toks": 51}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    9.4 General Manufacturing Information\n\nEPA TSCA Commercial Activity Status\n\n1,3-Propanediol, 2-methyl-2-propyl-, 1,3-dicarbamate: ACTIVE\n\nThis is a controlled substance (depressant): 21CFR1308.14\n\nO'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Whitehouse Station, NJ: Merck and Co., Inc., 2006., p. 1013\n\n10 Identification\n\n10.1 Analytic Laboratory Methods\n\nAnalyte: meprobamate; matrix: chemical identification; procedure: infrared absorption spectrophotometry of potassium bromide dispersion with comparison to standards.\n\nU.S. Pharmacopeia. The United States Pharmacopeia, USP 31/The National Formulary, NF 26; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2623 (2008)\n\nAnalyte: meprobamate; matrix: chemical identification; procedure: thin-layer chromatography with comparison to standards\n\n\n                    Context: \n                    This section transitions from general manufacturing information about meprobamate, including regulatory status and controlled substance classification, to its identification methods, specifically outlining standard analytical techniques such as infrared spectrophotometry and thin-layer chromatography used for laboratory confirmation and purity analysis.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_53", "document_index": 50, "latency_s": 63.82894789997954, "prompt_toks": 28443, "completion_toks": 99}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Analyte: meprobamate; matrix: chemical identification; procedure: thin-layer chromatography with comparison to standards\n\nU.S. Pharmacopeia. The United States Pharmacopeia, USP 31/The National Formulary, NF 26; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2623 (2008)\n\nAnalyte: meprobamate; matrix: chemical purity; procedure: dissolution with hydrochloric acid; reflux; addition of water and methyl red indicator; neutralization with sodium hydroxide until color changes from pink\n\nU.S. Pharmacopeia. The United States Pharmacopeia, USP 31/The National Formulary, NF 26; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2624 (2008)\n\nAnalyte: meprobamate; matrix: pharmaceutical preparation (oral suspension); procedure: reaction with acetone, furfural in glacial acetic acid and hydrochloric acid; formation of purple color, changing to blue, blue-black and finally black-brown on standing (chemical identification)\n\n\n                    Context: \n                    These entries are part of a section detailing analytic laboratory methods for identifying and assessing the purity of meprobamate in various matrices, as found in the U.S. Pharmacopeia. They describe specific procedures—such as thin-layer chromatography, titration with acid-base indicators, and color reactions in pharmaceutical preparations—used for the qualitative and quantitative analysis of meprobamate within quality control and regulatory settings. This information is situated within broader safety, manufacturing, and identification protocols for the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_54", "document_index": 50, "latency_s": 49.019354499992914, "prompt_toks": 28481, "completion_toks": 102}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    U.S. Pharmacopeia. The United States Pharmacopeia, USP 31/The National Formulary, NF 26; Rockville, MD: U.S. Pharmacopeial Convention, Inc., p.2624 (2008)\n\nFor more Analytic Laboratory Methods (Complete) data for MEPROBAMATE (13 total), please visit the HSDB record page.\n\n10.2 Clinical Laboratory Methods\n\nAnalyte: meprobamate; matrix: blood (serum); procedure: high-performance liquid chromatography with ultraviolet detection at 190 nm; limit of detection: 2000 ng/mL\n\nVan Damme M et al; J Toxicol Clin Toxicol 23: 589-614 (1985). As cited in Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\nAnalyte: meprobamate; matrix: pharmaceutical preparation; procedure: high-performance liquid chromatography with ultraviolet detection at 273 nm\n\nBechet I et al; J Pharm Biomed Anal 10: 995-9 (1992). As cited in Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\n\n                    Context: \n                    This section appears within the \"Identification\" part of the document, specifically under \"Clinical Laboratory Methods,\" following the \"Analytic Laboratory Methods\" subsection. It details standardized laboratory procedures for detecting meprobamate in biological samples (such as blood serum) and pharmaceutical preparations, highlighting analytical methods like high-performance liquid chromatography with ultraviolet detection. These methods are relevant for clinical toxicology, therapeutic drug monitoring, and quality control, providing practical information for laboratory analysis of meprobamate in medical and forensic contexts.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_55", "document_index": 50, "latency_s": 57.33001920001698, "prompt_toks": 28515, "completion_toks": 96}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Bechet I et al; J Pharm Biomed Anal 10: 995-9 (1992). As cited in Lunn G; HPLC and CE Methods for Pharmaceutical Analysis. CD-ROM. New York, NY: John Wiley & Sons (2000)\n\nTYPE A PROCEDURE (SIMPLE, DIRECT & QUALITATIVE) USING PLASMA OR URINE; THIN LAYER CHROMATOGRAPHY METHOD WITH NO INTERFERING SUBSTANCES.\n\nSunshine, Irving (ed.) Methodology for Analytical Toxicology. Cleveland: CRC Press, Inc., 1975., p. 219\n\nTYPE C PROCEDURE (ELEGANT & PRECISE, USING REQUIRED EQUIPMENT) FOR BLOOD, GASTRIC CONTENT, URINE OR HOMOGENIZED TISSUE; GAS CHROMATOGRAPHY METHOD CAN DETECT CONCN OF 2 UG/ML & IS ACCURATE TO PLUS OR MINUS 0.5 UG/ML RANGING FROM 10-100 UG/ML. THERE ARE NO COMMON DRUGS OR POISONS THAT WILL INTERFERE WITH THIS PROCEDURE.\n\nSunshine, Irving (ed.) Methodology for Analytical Toxicology. Cleveland: CRC Press, Inc., 1975., p. 222\n\nFor more Clinical Laboratory Methods (Complete) data for MEPROBAMATE (8 total), please visit the HSDB record page.\n\n11 Safety and Hazards\n\n\n                    Context: \n                    This chunk appears in the section detailing clinical laboratory methods for detecting and analyzing meprobamate in biological samples. It lists specific analytical techniques—including HPLC with UV detection, thin-layer chromatography using plasma or urine, and gas chromatography for various tissues—used for qualitative and quantitative measurements of meprobamate in clinical and toxicological settings. This section precedes the broader \"Safety and Hazards\" section and provides practical information for laboratory identification and measurement of the substance.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_56", "document_index": 50, "latency_s": 54.264045700023416, "prompt_toks": 28435, "completion_toks": 77}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    For more Clinical Laboratory Methods (Complete) data for MEPROBAMATE (8 total), please visit the HSDB record page.\n\n11 Safety and Hazards\n\n11.1 Hazards Identification\n\n11.1.1 GHS Classification\n\nPictogram(s)\n\nIrritant\n\nSignal\n\nWarning\n\nGHS Hazard Statements\n\nH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]\n\nPrecautionary Statement Codes\n\nP264, P270, P301+P317, P330, and P501\n\n(The corresponding statement to each P-code can be found at the GHS Classification page.)\n\nECHA C&L Notifications Summary\n\nAggregated GHS information provided per 42 reports by companies from 1 notifications to the ECHA C&L Inventory.\n\nInformation may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.\n\n\n                    Context: \n                    This section introduces the \"Safety and Hazards\" information for Meprobamate, beginning with its GHS (Globally Harmonized System) classification. It details hazard identification, associated pictograms, signal words, hazard and precautionary statements, and summarizes regulatory notifications, providing essential regulatory and toxicological context following sections on laboratory methods and preceding in-depth safety measures and handling guidelines.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_57", "document_index": 50, "latency_s": 59.968980000005104, "prompt_toks": 28244, "completion_toks": 71}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.1.2 Hazard Classes and Categories\n\nAcute Tox. 4 (100%)\n\n11.1.3 Health Hazards\n\n\n                    Context: \n                    This section appears in the broader \"Safety and Hazards\" chapter of the meprobamate compound record, specifically within the \"Hazards Identification\" subsection. It details regulatory hazard classification codes and summarizes associated health risks from exposure, immediately following the GHS pictogram and signal word, and precedes an in-depth discussion of clinical symptoms and health effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_58", "document_index": 50, "latency_s": 58.20623710000655, "prompt_toks": 28451, "completion_toks": 64}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    SYMPTOMS: Symptoms of exposure upon ingestion of this compound may include coma, blood pressure decrease, regional or general arteriolar constriction, dyspnea, cyanosis, respiratory depression, nausea, vomiting and allergic skin dermatitis. Other symptoms may include slight alterations of binocular vision and slight tendency to euphoria. Exposure to this compound may also cause drowsiness, diarrhea, paresthesia, weakness, headache, excitement, dizziness, ataxia, disturbances of vision, tachycardia, erythema multiform and, occasionally, skin rashes, angioneurotic edema, bronchospasm, anuria, agranulocytosis, eosinophilia, leucopenia and aplastic anemia. Other symptoms may include purpura, hypotension, cardiac arrhythmias and, occasionally, urticaria and thrombocytopenia. Exposure to this compound may result in acute intermittent porphyria, allergic or idiosyncratic reactions, slurred speech, vertigo, overstimulation, fast EEG activity, palpitations, arrhythmia, transient ECG changes,\n\n\n                    Context: \n                    This chunk appears in the \"Safety and Hazards\" section of the Meprobamate compound page, specifically under \"Hazards Identification.\" It details the acute and chronic health symptoms associated with exposure to meprobamate, listing potential effects from ingestion and other exposure routes to inform about toxicological risks and clinical manifestations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_59", "document_index": 50, "latency_s": 48.11331149999751, "prompt_toks": 28446, "completion_toks": 88}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    compound may result in acute intermittent porphyria, allergic or idiosyncratic reactions, slurred speech, vertigo, overstimulation, fast EEG activity, palpitations, arrhythmia, transient ECG changes, syncope, hypotensive crises, petechiae, ecchymoses, peripheral edema, adenopathy, fever, lethargy, stupor, shock, vasomotor and respiratory collapse, death, increased risk of congenital malformations and, rarely, hyperpyrexia, chills, oliguria, exfoliative dermatitis, anaphylaxis, stomatitis, proctitis, Stevens-Johnson syndrome and bullous dermatitis. Central nervous system depression may also occur. Other symptoms may include blood dyscrasias and hypothermia. Exposure to this compound also causes sleepiness, unsteadiness, mental confusion, slow and shallow respiration, flaccid muscles, hyperthermia, aspiration pneumonia, signs of lung consolidation, cerebral edema, laryngospasm, hangover emotional lability or depression, irritability, poor judgment, behavioral disturbances, vascular\n\n\n                    Context: \n                    This passage is part of the \"Hazards Identification\" section, specifically under \"Health Hazards,\" where the document lists the acute and chronic symptoms, complications, and adverse reactions that can occur following exposure to meprobamate, a controlled anxiolytic drug. It details severe outcomes including neurological, cardiovascular, and dermatological effects, as well as risks like porphyria, congenital malformations, and potential fatality.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_60", "document_index": 50, "latency_s": 55.50576329999603, "prompt_toks": 28354, "completion_toks": 41}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    aspiration pneumonia, signs of lung consolidation, cerebral edema, laryngospasm, hangover emotional lability or depression, irritability, poor judgment, behavioral disturbances, vascular collapse, cardiac arrest and nonthrombocytopenic purpura. Other symptoms may include erythematous rash, angioedema, impaired stance and heart failure. In addition, areflexia, lack of response to sensory stimuli, excess oronasal secretions, relaxation of the pharyngeal wall muscular relaxation, pruritic eruptions, anaphylactoid reaction, fatal allergic collapse, fixed and unresponsive pupils, atelectasis and epileptiform seizures may occur.\n\n\n                    Context: \n                    This passage lists potential symptoms and health hazards observed upon exposure to meprobamate, particularly in cases of overdose or poisoning, as part of the document's comprehensive section on hazards identification and toxicological effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_61", "document_index": 50, "latency_s": 57.33110169999418, "prompt_toks": 28373, "completion_toks": 77}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ACUTE/CHRONIC HAZARDS: When heated to decomposition this compound emits toxic fumes of nitrogen oxides. (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\n11.1.4 Fire Hazards\n\nFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\n11.2 First Aid Measures\n\n11.2.1 First Aid\n\n\n                    Context: \n                    This chunk appears in the safety and hazards section of the Meprobamate compound page, specifically discussing the acute and chronic hazards related to fire and thermal decomposition, such as the emission of toxic nitrogen oxide fumes, probable combustibility, and relevant first aid measures. It provides critical chemical hazard information for safe handling, emergency response, and fire-related risks associated with Meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_62", "document_index": 50, "latency_s": 53.60136679999414, "prompt_toks": 28378, "completion_toks": 61}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.2 First Aid Measures\n\n11.2.1 First Aid\n\nEYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. If symptoms (such as redness or irritation) develop, immediately transport the victim to a hospital.\n\nSKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.\n\n\n                    Context: \n                    This section provides detailed first aid instructions for exposure to meprobamate, addressing emergency response procedures for eye and skin contact. It is part of the broader Safety and Hazards section of the document, which outlines hazard identification, health effects, handling, storage, and emergency measures for incidents involving this chemical.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_63", "document_index": 50, "latency_s": 55.67938499999582, "prompt_toks": 28329, "completion_toks": 63}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing.\n\n\n                    Context: \n                    This chunk provides first aid instructions for inhalation exposure to meprobamate, detailing immediate steps to take if someone breathes in the chemical and the recommended protective equipment for rescuers. It is part of the Safety and Hazards section, specifically under First Aid Measures, offering guidance on emergency response to accidental exposure.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_64", "document_index": 50, "latency_s": 56.372919199988246, "prompt_toks": 28421, "completion_toks": 65}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\n11.3 Fire Fighting\n\nFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)\n\n\n                    Context: \n                    This chunk is from the Safety and Hazards section of the Meprobamate compound page, specifically within the First Aid Measures subsection. It provides emergency instructions for ingestion of meprobamate, outlining immediate steps to take and emphasizing not to induce vomiting, followed by guidance for fire fighting in case of fires involving the substance.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_65", "document_index": 50, "latency_s": 55.03557119998732, "prompt_toks": 28377, "completion_toks": 78}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.3 Fire Fighting\n\nFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\n11.4 Accidental Release Measures\n\n11.4.1 Disposal Methods\n\nSRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.\n\n11.5 Handling and Storage\n\n11.5.1 Nonfire Spill Response\n\n\n                    Context: \n                    This section is part of the broader \"Safety and Hazards\" chapter for meprobamate, detailing practical information for emergency response and occupational safety. It provides guidance on fire-fighting approaches for incidents involving meprobamate, outlines disposal recommendations for accidental release or spills, and introduces protocols for handling, storage, and non-fire spill response, supporting safe management of this controlled pharmaceutical substance.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_66", "document_index": 50, "latency_s": 56.771999899996445, "prompt_toks": 28387, "completion_toks": 78}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.5 Handling and Storage\n\n11.5.1 Nonfire Spill Response\n\nSMALL SPILLS AND LEAKAGE: Should a spill occur while you are handling this chemical, FIRST REMOVE ALL SOURCES OF IGNITION, then you should dampen the solid spill material with 60-70% ethanol and transfer the dampened material to a suitable container. Use absorbent paper dampened with 60-70% ethanol to pick up any remaining material. Seal the absorbent paper, and any of your clothes, which may be contaminated, in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with 60-70% ethanol followed by washing with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.\n\n\n                    Context: \n                    This section provides specific guidance on safe procedures for cleaning up small spills of meprobamate, a controlled depressant and chemical irritant, as part of the broader safety, handling, and storage information detailed in the document. It outlines immediate actions to prevent fire hazards and environmental contamination, complementing other chemical hazard, first aid, storage, and disposal protocols presented for meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_67", "document_index": 50, "latency_s": 55.06976450001821, "prompt_toks": 28427, "completion_toks": 113}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    STORAGE PRECAUTIONS: You should store this material under ambient temperatures. This compound is a Schedule IV DEA Controlled Substance and is to be stored according to State and Federal Regulations. Refer to Code of Federal Regulations Title 21 Part 1300 to End. (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\n11.5.2 Storage Conditions\n\nMeprobamate preparations generally should be stored in tight containers at a temperature less than 40 °C, preferably at 15-30 °C. However, USP states that the tablets can be stored in well-closed containers. The fixed-combination tablets of meprobamate and aspirin should be stored in tight, light-resistant containers at 20-25 °C and protected from moisture.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n\n                    Context: \n                    This section provides detailed guidance on the proper storage of meprobamate and its preparations, highlighting regulatory requirements due to its classification as a Schedule IV DEA controlled substance. It outlines general and specific storage conditions—such as temperature ranges, container type, and protection from moisture—for both meprobamate alone and in combination products (e.g., with aspirin), ensuring safety, compliance, and drug integrity. This content is part of the broader safety and handling information presented in the document, specifically within the \"Handling and Storage\" and \"Storage Conditions\" subsections.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_68", "document_index": 50, "latency_s": 56.73536239998066, "prompt_toks": 28411, "completion_toks": 76}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n11.6 Exposure Control and Personal Protection\n\n11.6.1 Personal Protective Equipment (PPE)\n\nRECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)\n\nNational Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.\n\n11.7 Stability and Reactivity\n\n11.7.1 Air and Water Reactions\n\nInsoluble in water.\n\n11.7.2 Reactive Group\n\nCarbamates\n\n11.7.3 Reactivity Profile\n\n\n                    Context: \n                    This section is part of the \"Safety and Hazards\" chapter of the Meprobamate compound profile, specifically detailing recommended personal protective equipment for laboratory handling, and introducing information on the chemical's physical stability, reactivity, and behavior in air and water. It follows guidance on exposure control and precedes detailed discussion of the compound’s chemical reactivity profile as a carbamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_69", "document_index": 50, "latency_s": 57.115790500014555, "prompt_toks": 28433, "completion_toks": 144}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.7 Stability and Reactivity\n\n11.7.1 Air and Water Reactions\n\nInsoluble in water.\n\n11.7.2 Reactive Group\n\nCarbamates\n\n11.7.3 Reactivity Profile\n\nMEPROBAMATE is a carbamate ester. Carbamates are chemically similar to, but more reactive than amides. Like amides they form polymers such as polyurethane resins. Carbamates are incompatible with strong acids and bases, and especially incompatible with strong reducing agents such as hydrides. Flammable gaseous hydrogen is produced by the combination of active metals or nitrides with carbamates. Strongly oxidizing acids, peroxides, and hydroperoxides are incompatible with carbamates.\n\n11.8 Regulatory Information\n\nCalifornia Safe Cosmetics Program (CSCP) Reportable Ingredient\n\nHazard Traits - Developmental Toxicity\n\nAuthoritative List - Prop 65\n\nReport - regardless of intended function of ingredient in the product\n\nDEA Controlled Substances\n\nDEA schedule IV controlled substance\n\n\n                    Context: \n                    Section 11.7 \"Stability and Reactivity\" provides information on meprobamate’s chemical behavior, including its insolubility in water, classification as a carbamate ester, typical reactions with acids, bases, reducing agents, and incompatibilities. This is immediately followed by Section 11.8 \"Regulatory Information,\" summarizing regulatory status, reporting requirements, and control measures under various agencies, such as California CSCP, Prop 65, and DEA scheduling. These sections are part of the document’s broader safety and hazard profile (Section 11), which covers identification, handling, personal protection, and legal status of meprobamate, supporting safe use and compliance for researchers and professionals.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_70", "document_index": 50, "latency_s": 52.624416399979964, "prompt_toks": 28331, "completion_toks": 86}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Authoritative List - Prop 65\n\nReport - regardless of intended function of ingredient in the product\n\nDEA Controlled Substances\n\nDEA schedule IV controlled substance\n\n21 CFR Sections 1308.11-1308.15 https://www.ecfr.gov/current/title-21/chapter-II/part-1308\n\nNew Zealand EPA Inventory of Chemical Status\n\n1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate: Does not have an individual approval but may be used under an appropriate group standard\n\n11.8.1 FDA Requirements\n\n\n                    Context: \n                    This chunk appears in the \"Regulatory Information\" section of the document, listing key regulatory classifications and requirements for meprobamate, including its designation under California Proposition 65 for developmental toxicity, its Schedule IV status as a controlled substance under the DEA, relevant U.S. federal regulations (21 CFR 1308), and its regulatory status in the New Zealand EPA Inventory. This is followed by specific FDA requirements for controlled substances.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_71", "document_index": 50, "latency_s": 56.91565019998234, "prompt_toks": 28401, "completion_toks": 97}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate: Does not have an individual approval but may be used under an appropriate group standard\n\n11.8.1 FDA Requirements\n\nSchedule IV shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: Meprobamate (DEA Code Number: 2820) is included on this list.\n\n\n                    Context: \n                    This section outlines regulatory and legal requirements for meprobamate, including its classification as a Schedule IV DEA-controlled substance (Depressant, DEA code 2820), as well as group standard approval status for 1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate in the New Zealand EPA inventory. It provides context for compliance, legal handling, and controlled status within the broader document's focus on safety, hazards, and regulatory information.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_72", "document_index": 50, "latency_s": 54.88372129999334, "prompt_toks": 28447, "completion_toks": 97}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    21 CFR 1308.14(c) (USFDA); U.S. National Archives and Records Administration's Electronic Code of Federal Regulations. Available from, as of July 13, 2009: https://www.ecfr.gov\n\nThe Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl meprobamate, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.\n\nDHHS/FDA; Electronic Orange Book-Approved Drug Products with Therapeutic Equivalence Evaluations. Available from, as of July 9, 2009: https://www.accessdata.fda.gov/scripts/cder/ob/docs/queryai.cfm\n\n11.9 Other Safety Information\n\nChemical Assessment\n\nIMAP assessments - 1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate: Environment tier I assessment\n\nIMAP assessments - 1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate: Human health tier I assessment\n\n11.9.1 Special Reports\n\n\n                    Context: \n                    This chunk appears within the \"Safety and Hazards\" section of the document, specifically under \"Regulatory Information,\" where it provides details about meprobamate's status as a controlled substance according to U.S. federal regulations (21 CFR 1308.14(c)), its FDA approval and inclusion in the Orange Book, and references to official regulatory resources for further information. This context directly precedes a summary of chemical assessments and special regulatory reports related to environmental and human health evaluations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_73", "document_index": 50, "latency_s": 58.23010640000575, "prompt_toks": 28479, "completion_toks": 87}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    IMAP assessments - 1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate: Human health tier I assessment\n\n11.9.1 Special Reports\n\nCarson J; Meprobamate revisited; 2 (2): 45-46 (1989). The history, clinical efficacy and adverse effects of meprobamate, a nonbenzodiazepine anxiolytic agent, are discussed. Meprobamate is found to have questionable efficacy and be more dangerous in overdose than benzodiazepines. Although potential for abuse is hard to quantify, it appears that meprobamate has equivalent, if not greater, potential for abuse when compared with benzodiazepines. It is concluded that an increase in meprobamate use would not be in the best interest of patients.\n\n12 Toxicity\n\n12.1 Toxicological Information\n\n12.1.1 USGS Health-Based Screening Levels for Evaluating Water-Quality\n\nChemical\n\nMeprobamate\n\nChemical Classes\n\nPharmaceutical\n\nReference\n\nSmith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP\n\n\n                    Context: \n                    This section appears in the \"Safety and Hazards\" part of the document, following regulatory and assessment subsections (such as IMAP human health assessments). It transitions into \"Special Reports,\" which discuss critical evaluations of meprobamate's safety and abuse potential, and then moves into the \"Toxicity\" section, which compiles detailed toxicological data including health-based screening levels, chemical class designations, and scholarly references.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_74", "document_index": 50, "latency_s": 52.40556210000068, "prompt_toks": 28282, "completion_toks": 72}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprobamate\n\nChemical Classes\n\nPharmaceutical\n\nReference\n\nSmith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP\n\n12.1.2 Hepatotoxicity\n\n\n                    Context: \n                    The chunk appears in the \"Toxicity\" section of the document, specifically under \"12.1 Toxicological Information.\" It introduces meprobamate as a pharmaceutical compound and directly precedes a subsection on hepatotoxicity, suggesting a focus on health-based evaluations of its toxicity, particularly regarding liver effects, with references to authoritative screening levels and recent literature.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_75", "document_index": 50, "latency_s": 56.72694449999835, "prompt_toks": 28431, "completion_toks": 99}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Reference\n\nSmith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP\n\n12.1.2 Hepatotoxicity\n\nRates of serum enzyme elevations during meprobamate therapy have not been reported. While instances of clinically apparent liver injury due to meprobamate have been mentioned in review articles, no cases with specific information on clinical features have appeared in the published literature. Thus, meprobamate may be capable of causing clinically apparent liver injury, but it must be rare. Meprobamate is metabolized in the liver via the cytochrome P450 system and has major potential for drug-drug interactions. Meprobamate can exacerbate symptoms of porphyria. Serious allergic reactions to meprobamate have been reported including Stevens Johnson syndrome. In cases of meprobamate overdose, the cause of death has been respiratory suppression and not liver failure, although liver histology was not well defined.\n\n\n                    Context: \n                    This section appears under \"12 Toxicity\" and presents information on the potential liver toxicity (hepatotoxicity) of meprobamate, summarizing current knowledge on liver enzyme changes, liver injury cases, drug metabolism, and hypersensitivity reactions. It addresses the rarity of clinically apparent liver injury with meprobamate use, its metabolism via the cytochrome P450 system leading to possible drug interactions, and notes serious but rare reactions like Stevens Johnson syndrome and its effects in overdose situations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_76", "document_index": 50, "latency_s": 57.28247229999397, "prompt_toks": 28463, "completion_toks": 84}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Likelihood score: E* (unproven but suspected cause of liver injury).\n\nDrug Class: Sedatives and Hypnotics, Miscellaneous\n\n12.1.3 Drug Induced Liver Injury\n\nCompound\n\nmeprobamate\n\nDILI Annotation\n\nNo-DILI-Concern\n\nLabel Section\n\nNo match\n\nReferences\n\nM Chen, V Vijay, Q Shi, Z Liu, H Fang, W Tong. FDA-Approved Drug Labeling for the Study of Drug-Induced Liver Injury, Drug Discovery Today, 16(15-16):697-703, 2011. PMID:21624500 DOI:10.1016/j.drudis.2011.05.007\n\nM Chen, A Suzuki, S Thakkar, K Yu, C Hu, W Tong. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 2016, 21(4): 648-653. PMID:26948801 DOI:10.1016/j.drudis.2016.02.015\n\n12.1.4 Effects During Pregnancy and Lactation\n\n◉ Summary of Use during Lactation\n\n\n                    Context: \n                    This section appears within the toxicity and safety information for meprobamate, specifically addressing its potential to cause drug-induced liver injury (DILI). It presents evidence assessments regarding the likelihood of meprobamate causing liver injury, referencing published studies and providing regulatory annotation. This information is part of a broader evaluation of meprobamate’s health risks, organized under the toxicological data and human safety profiles in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_77", "document_index": 50, "latency_s": 53.19092969998019, "prompt_toks": 28407, "completion_toks": 85}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    12.1.4 Effects During Pregnancy and Lactation\n\n◉ Summary of Use during Lactation\n\nBecause there is little published experience with meprobamate during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant, or when other drugs that can cause sedation are used simultaneously. If meprobamate is required by the mother, it is not necessarily a reason to discontinue breastfeeding. Monitor the infant for sedation, poor feeding and poor weight gain.\n\n◉ Effects in Breastfed Infants\n\nRelevant published information was not found as of the revision date.\n\n◉ Effects on Lactation and Breastmilk\n\nOne paper reported that some psychiatric patients receiving meprobamate alone or in combination with other psychotropic drugs developed galactorrhea. Further details of meprobamate use were not reported.\n\n12.1.5 Acute Effects\n\n12.1.6 Interactions\n\n\n                    Context: \n                    Section 12.1.4 appears in the Toxicity chapter of the Meprobamate compound page, specifically within the Toxicological Information section. It provides summarized information on the effects of meprobamate use during pregnancy and lactation, including considerations for breastfeeding mothers, effects on breastfed infants, and possible impacts on lactation and breastmilk. This section is followed by content on acute effects and drug interactions.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_78", "document_index": 50, "latency_s": 57.57589639999787, "prompt_toks": 28437, "completion_toks": 117}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    12.1.5 Acute Effects\n\n12.1.6 Interactions\n\nExcretion of meprobamate may be incr to point of net tubular secretion by addn of furosemide to saline diuresis. This resulted in excretion of 35% of admin dose of meprobamate over 4 hr period.\n\nPMID:4838229\n\nGibson TP et al; Clin Toxicol 7: 29 (1974)\n\nAlthough animal studies indicated that meprobamate shortened the half-life of warfarin, subsequent human studies have shown the meprobamate does not have any clinically important effect on warfarin-induced hypoprothrombinemia.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nAlthough imipramine enhances the CNS effects of meprobamate in animals, no clinically important effect of this interaction has been documented in humans.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n\n                    Context: \n                    This chunk appears under the \"12 Toxicity\" section of the Meprobamate compound profile, specifically within the subsections detailing acute effects and drug interactions. It summarizes findings on how meprobamate's excretion can be increased by co-administration with furosemide, as well as evidence regarding its potential interactions with other drugs such as warfarin and imipramine, noting that no significant clinical effects have been observed in humans. This context is part of a broader discussion regarding the toxicological properties, adverse effects, and safety considerations of meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_79", "document_index": 50, "latency_s": 57.222084300010465, "prompt_toks": 28424, "completion_toks": 115}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nAdditive CNS depression may occur when meprobamate is administered concomitantly with other CNS depressants, including alcohol. If meprobamate is used concomitantly with other depressant drugs, including alcohol, caution should be used to avoid overdosage.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nFor more Interactions (Complete) data for MEPROBAMATE (6 total), please visit the HSDB record page.\n\n12.1.7 Antidote and Emergency Treatment\n\nEmergency and supportive measures: Maintain an open airway and assist ventilation if necessary. Administer supplemental oxygen. Treat coma, hypothermia, hypotension, and pulmonary edema if they occur. Monitor patients for at least 6 hours after ingestion, because delayed absorption may occur. ... /Sedative-hypnotic agents/\n\n\n                    Context: \n                    This section is part of the comprehensive safety, toxicity, and clinical management information for meprobamate, specifically addressing drug interactions and emergency treatment protocols. It highlights the risk of additive central nervous system (CNS) depression when meprobamate is combined with other CNS depressants like alcohol, and provides guidance on supportive measures and patient monitoring in cases of overdose or poisoning. This content is found within the broader \"Toxicity\" and \"Antidote and Emergency Treatment\" subsections, which are included in the extensive safety and hazard overview for meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_80", "document_index": 50, "latency_s": 52.88253910001367, "prompt_toks": 28455, "completion_toks": 85}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Olson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 338\n\nDecontamination: Administer activated charcoal orally if conditions are appropriate. Gastric lavage is not necessary after small to moderate ingestions if activated charcoal can be given promptly. /Sedative-hypnotic agents/\n\nOlson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 338\n\nEnhanced elimination: ... Meprobamate has a relatively small volume of distribution (0.7 L/kg), and hemoperfusion may be useful for deep coma complicated by intractable hypotension. /Sedative-hypnotic agents/\n\nOlson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 338\n\n\n                    Context: \n                    This excerpt appears in the Toxicity section of the Meprobamate compound page, specifically under \"Antidote and Emergency Treatment.\" It provides clinical recommendations for managing meprobamate overdose, including the use of activated charcoal for decontamination and hemoperfusion for enhanced elimination in severe cases. This guidance is part of a broader set of toxicological and safety information relevant to healthcare professionals responding to poisoning or overdose situations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_81", "document_index": 50, "latency_s": 56.105143799999496, "prompt_toks": 28408, "completion_toks": 91}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Olson, K.R. (Ed.); Poisoning & Drug Overdose. 5th ed. Lange Medical Books/McGraw-Hill. New York, N.Y. 2007., p. 338\n\nIt has been estimated that one hemodialysis or hemoperfusion removes 7% to 17% of ingested meprobamate. Significant reduction in meprobamate elimination half lives has been demonstrated with charcoal and resin hemoperfusion and continuous arteriovenous hemoperfusion, indicating a possible role for these techniques.\n\nDart, R.C. (ed). Medical Toxicology. Third Edition, Lippincott Williams & Wilkins. Philadelphia, PA. 2004., p. 895\n\nFor more Antidote and Emergency Treatment (Complete) data for MEPROBAMATE (8 total), please visit the HSDB record page.\n\n12.1.8 Human Toxicity Excerpts\n\n\n                    Context: \n                    This chunk appears in the \"Antidote and Emergency Treatment\" subsection of the \"Toxicity\" section, detailing interventions for meprobamate overdose. It provides data on the effectiveness of hemodialysis, hemoperfusion, and other elimination techniques for removing meprobamate from the body, situating this clinical guidance within broader information on meprobamate's toxicology, management of poisoning, and treatment protocols presented in the overall document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_82", "document_index": 50, "latency_s": 55.493075000005774, "prompt_toks": 28448, "completion_toks": 98}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    For more Antidote and Emergency Treatment (Complete) data for MEPROBAMATE (8 total), please visit the HSDB record page.\n\n12.1.8 Human Toxicity Excerpts\n\n/SIGNS AND SYMPTOMS/ Sudden withdrawal of the drug after prolonged and excessive use may precipitate recurrence of pre-existing symptoms such as anxiety, anorexia, insomnia, or withdrawal reactions such as vomiting, ataxia, tremors, muscle twitching, confusional states, hallucinosis, and rarely, convulsive seizures. Such seizures are more likely to occur in persons with central nervous system damage or pre-existent or latent convulsive disorders. Onset of withdrawal symptoms occurs usually within 12 to 48 hours after discontinuation of meprobamate; symptoms usually cease within the next 12 to 48 hours.\n\nUS Natl Inst Health; DailyMed. Current Medication Information for Meprobamate (April 2004). Available from, as of June 16, 2009: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3775\n\n\n                    Context: \n                    This excerpt appears in the Toxicity section of the Meprobamate compound page, specifically under Human Toxicity Excerpts. It details the withdrawal symptoms and risks associated with abrupt discontinuation of meprobamate following prolonged and excessive use, highlighting clinical observations relevant to human health and safety. This content follows information on antidotes and emergency treatment for Meprobamate overdose and is part of a broader discussion of human and non-human toxicity, safety, and clinical effects of the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_83", "document_index": 50, "latency_s": 58.02180610000505, "prompt_toks": 28427, "completion_toks": 92}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    US Natl Inst Health; DailyMed. Current Medication Information for Meprobamate (April 2004). Available from, as of June 16, 2009: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3775\n\n/SIGNS AND SYMPTOMS/ Physical dependence, psychological dependence, and abuse have occurred. When chronic intoxication from prolonged use occurs, it usually involves ingestion of greater than recommended doses and is manifested by ataxia, slurred speech, and vertigo. Therefore, careful supervision of dose and amounts prescribed is advised, as well as avoidance of prolonged administration, especially for alcoholics and other patients with a known propensity for taking excessive quantities of drugs.\n\nUS Natl Inst Health; DailyMed. Current Medication Information for Meprobamate (April 2004). Available from, as of June 16, 2009: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3775\n\n\n                    Context: \n                    This excerpt appears in the \"Human Toxicity Excerpts\" section of the Meprobamate compound page, under the broader \"Toxicity\" and \"Safety and Hazards\" content areas. It provides details on physical and psychological dependence, abuse potential, and symptoms associated with chronic intoxication due to prolonged or excessive use of meprobamate, emphasizing the need for careful supervision and restricted duration of therapy, especially in individuals prone to substance misuse.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_84", "document_index": 50, "latency_s": 52.82866609998746, "prompt_toks": 28382, "completion_toks": 74}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    US Natl Inst Health; DailyMed. Current Medication Information for Meprobamate (April 2004). Available from, as of June 16, 2009: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3775\n\n/SIGNS AND SYMPTOMS/ Tolerance and psychologic and physical dependence may occur following prolonged use of high doses of meprobamate. Daily ingestion of 3.2 g of meprobamate for weeks or months has produced physical dependence and withdrawal symptoms when the drug was suddenly discontinued. Because of the drug's potential for inducing dependence, prolonged administration of meprobamate is not recommended.\n\nAmerican Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n\n                    Context: \n                    This excerpt appears in the toxicity and safety section of the document and discusses the risks of tolerance, psychological and physical dependence, and withdrawal associated with prolonged high-dose use of meprobamate. It highlights that chronic ingestion can lead to dependence and withdrawal symptoms upon sudden discontinuation, underscoring the recommendation against extended use due to the drug's potential for inducing dependence.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_85", "document_index": 50, "latency_s": 57.07066379999742, "prompt_toks": 28411, "completion_toks": 90}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\n/SIGNS AND SYMPTOMS/ Symptoms of meprobamate dependence are similar to those of barbiturate dependence or chronic alcoholism and may include drowsiness, ataxia, slurred speech, and vertigo. Sudden discontinuance of the drug in physically dependent patients may produce severe withdrawal symptoms within 12-48 hours including anxiety, anorexia, insomnia, vomiting, ataxia, tremors, muscle twitching, confusion, hallucinations, and seizures clinically indistinguishable from generalized tonic-clinic (grand mal) seizures. Seizures are most likely to occur in patients ingesting large amounts of the drug or patients who have CNS damage or a history of seizure disorders. Some fatalities have occurred following abrupt withdrawal of meprobamate. Withdrawal symptoms usually cease within 12-48 hours they appear.\n\n\n                    Context: \n                    This passage appears in the section detailing the toxicological effects and risks of meprobamate, specifically under human toxicity and dependence. It describes the symptoms and dangers associated with meprobamate dependence and withdrawal, highlighting similarities to barbiturate and alcohol dependence. The context is part of a comprehensive overview of meprobamate’s adverse effects, focusing on clinical signs, withdrawal syndromes, potential for fatal outcomes, and recommendations for safe use.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_86", "document_index": 50, "latency_s": 55.2091924000124, "prompt_toks": 28458, "completion_toks": 98}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)\n\nFor more Human Toxicity Excerpts (Complete) data for MEPROBAMATE (18 total), please visit the HSDB record page.\n\n12.1.9 Non-Human Toxicity Excerpts\n\n/LABORATORY ANIMALS: Acute Exposure/ The intraocular pressure in rabbits has been found reduced only by very large doses (400 mg per rabbit) which also produced mydriasis.\n\nGrant, W.M. Toxicology of the Eye. 3rd ed. Springfield, IL: Charles C. Thomas Publisher, 1986., p. 577\n\n/LABORATORY ANIMALS: Acute Exposure/ ACUTE TOXICITY STUDIES ON LAB ANIMALS HAVE DEMONSTRATED THAT MEPROBAMATE IS 4-5 TIMES LESS TOXIC THAN MOST BARBITURATES.\n\nGosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. III-259\n\n\n                    Context: \n                    This section is part of the broader \"Toxicity\" chapter, specifically under \"Non-Human Toxicity Excerpts.\" It provides summarized findings from animal studies on the acute toxicity and physiological effects of meprobamate in laboratory animals, comparing its toxicity profile to that of barbiturates and noting specific observed outcomes at high doses. This content follows the \"Human Toxicity Excerpts\" and precedes detailed non-human toxicity values, supporting literature, and other safety data.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_87", "document_index": 50, "latency_s": 56.56448260002071, "prompt_toks": 28442, "completion_toks": 105}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Gosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. III-259\n\n/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ ... Pregnant rats /were given/ 60 mg per kg /meprobamate/ on days 5 through 8, 11 through 14 or 17 through 20 and then ... several learning tests /were carried out/ postnatally. Although ... decreased scores /were reported/ in all treated groups, /another experiment/ using similar conditions /was/ unable to confirm their work. /This/ later /experiment/ also reviewed the clinical literature and reported absence of teratogenic acitivity. ... Learning impairment in the offspring /could not be demonstrated in an experiment/ using up to 128 mg per kg in the rat's diet during the entire gestation period. Lethal doses (750 mg per kg) in the mouse produced some skeletal defects but lower doses did not produce defects.\n\n\n                    Context: \n                    This excerpt appears in the section summarizing non-human toxicity studies of meprobamate, specifically focusing on developmental and reproductive toxicity. It presents findings from animal experiments examining the effects of meprobamate on pregnant rats and mice, reporting inconclusive evidence for teratogenicity and learning impairment at sublethal doses, with only high (lethal) doses linked to skeletal defects. This context is part of the document's broader review of meprobamate's toxicity profiles in laboratory animals to inform risk and safety assessments.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_88", "document_index": 50, "latency_s": 53.66816729999846, "prompt_toks": 28250, "completion_toks": 48}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Shepard, T.H. Catalog of Teratogenic Agents. 5th ed. Baltimore, MD: The Johns Hopkins University Press, 1986., p. 361\n\n\n                    Context: \n                    This citation appears in the section discussing non-human toxicity of Meprobamate, specifically relating to developmental or reproductive toxicity studies conducted in laboratory animals, such as rats and mice, examining teratogenic and learning effects following exposure during gestation.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_89", "document_index": 50, "latency_s": 55.94828579999739, "prompt_toks": 28460, "completion_toks": 69}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    /LABORATORY ANIMALS: Neurotoxicity/ The physical dependence potential of meprobamate (MPB) was compared with that of phenobarbital (PHB) and codeine (COD) to ascertain whether MPB produces definite physical dependence in the rat. Rats were treated orally with MPB (maintenance dosage = 800 mg/kg X 2/day), PHB (100 X 2) or COD (50 X 2) twice a day (10:00 a.m. and 5:00 p.m.) for a total of 21 days; the treatment was ceased for 3 days after administration for 7 days, and the last dosing was performed on day 27. During intoxication and after the withdrawal, the MPB treated rats exhibited behaviour and withdrawal signs similar to those seen in the PHB treated rats, but not the COD treated rats. After withdrawal of drugs, definite weight loss was observed in all the rats given drugs, and the recovery of the MPB and PHB treated rats was clearly later than that of the COD treated rats. A long-lasting increase in rectal temperature was observed after the withdrawal in the MPB and PHB treated\n\n\n                    Context: \n                    This excerpt appears in the toxicity section of the Meprobamate compound page, specifically under non-human toxicity studies. It provides details from a laboratory animal neurotoxicity study comparing the physical dependence potential of meprobamate to phenobarbital and codeine in rats, discussing withdrawal effects and physiological responses after repeated dosing and cessation.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_90", "document_index": 50, "latency_s": 55.24632649999694, "prompt_toks": 28312, "completion_toks": 89}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    of the MPB and PHB treated rats was clearly later than that of the COD treated rats. A long-lasting increase in rectal temperature was observed after the withdrawal in the MPB and PHB treated rats; a decrease was seen in the COD treated rats. From these results, it is concluded that definite physical dependence on MPB, similar to that on PHB but different from that on COD, was developed after repeated oral administration for a total of 21 days in the rat.\n\n\n                    Context: \n                    This excerpt discusses results from animal studies comparing the physical dependence potential of meprobamate (MPB), phenobarbital (PHB), and codeine (COD) in rats. It is part of the broader toxicology section of the document, specifically within non-human toxicity data, illustrating that meprobamate produces physical dependence in rats after repeated dosing, with withdrawal effects similar to phenobarbital but distinct from codeine.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_91", "document_index": 50, "latency_s": 55.716081299993675, "prompt_toks": 28533, "completion_toks": 72}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:6686852\n\nNakamura H, Shimizu M; Jpn J Pharmacol 33(6): 1171-6 (1983).\n\nFor more Non-Human Toxicity Excerpts (Complete) data for MEPROBAMATE (6 total), please visit the HSDB record page.\n\n12.1.10 Non-Human Toxicity Values\n\nLD50 Rat oral 794 mg/kg\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2554\n\nLD50 Rat ip 410 mg/kg\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2554\n\nLD 50 Rat ip 350 mg/kg\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2554\n\nLD50 Mouse oral 750 mg/kg\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2554\n\n\n                    Context: \n                    This section provides quantitative non-human toxicity data for meprobamate, specifically listing median lethal dose (LD50) values in rats and mice via oral and intraperitoneal administration. It follows a summary of experimental animal studies on meprobamate’s acute and dependence-related effects and precedes further detailed toxicity data within the document’s comprehensive toxicological profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_92", "document_index": 50, "latency_s": 57.391094300022814, "prompt_toks": 28463, "completion_toks": 107}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LD50 Mouse oral 750 mg/kg\n\nLewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 2554\n\nFor more Non-Human Toxicity Values (Complete) data for MEPROBAMATE (11 total), please visit the HSDB record page.\n\n12.1.11 Populations at Special Risk\n\nThe question whether certain benzodiazepines and minor tranquillizers decrease the action of low-dose oral contraceptives due to interaction between these drugs was addressed by examining 72 women taking these drugs concurrently. Drug interaction causing pregnancy was not observed. Spotting was observed in an extremely high number of cases taking meprobamate or chlordiazepoxide. In 76.9% of these cases causal relation could be proved by the discontinuance of anxiolytic or by changing to another psychopharmacon.\n\nPMID:1971733\n\nSomos P; Ther Hung 38 (1): 37-40 (1990)\n\nMeprobamate occasionally may precipitate seizures in epileptic patients.\n\n\n                    Context: \n                    This section provides specific non-human acute toxicity data for meprobamate, reporting an oral LD50 value in mice, and is part of the broader toxicity profile detailing experimental toxicity values. It precedes the discussion on special risk populations, which addresses drug interactions and adverse reactions in vulnerable human groups, such as women using oral contraceptives and epileptic patients. This content is located in the comprehensive \"Toxicity\" section, which examines meprobamate's effects, toxicity values, and risks across animal studies and human populations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_93", "document_index": 50, "latency_s": 54.22452909999993, "prompt_toks": 28512, "completion_toks": 65}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PMID:1971733\n\nSomos P; Ther Hung 38 (1): 37-40 (1990)\n\nMeprobamate occasionally may precipitate seizures in epileptic patients.\n\nUS Natl Inst Health; DailyMed. Current Medication Information for Meprobamate (April 2004). Available from, as of June 16, 2009: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3775\n\n12.2 Ecological Information\n\n12.2.1 Ecotoxicity Values\n\nUSDA APHIS Chemical Effects\n\nSchafer, E. W., Jr., W. A. Bowles Jr., and J. Hurlbut. 1983. The acute oral toxicity and repellency and hazard potential of 998 chemicals to one or more species of wild and domestic birds. Archives of Environmental Contamination and Toxicology 12:355-382. https://www.aphis.usda.gov/ws/nwrc/chem-effects-db/Q_schafer832.pdf\n\nSchafer, E.W. Jr. and D.J. Cummings. 1972. An evaluation of 148 compounds as avian immobilizing agents. U.S. Fish and Wildlife Service, Special Scientific Report-Wildlife No.150. 30pp. https://www.aphis.usda.gov/ws/nwrc/chem-effects-db/E_SchaferCunningham72.pdf\n\n\n                    Context: \n                    This section appears within the broader Toxicity and Safety data on Meprobamate, transitioning from human toxicity—specifically, risks for special populations such as epileptic patients—to a new subsection detailing the compound’s ecological and environmental impact, beginning with its acute toxicity in wildlife and birds as documented in key ecotoxicology studies.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_94", "document_index": 50, "latency_s": 56.15789760000189, "prompt_toks": 28226, "completion_toks": 106}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    12.2.2 Environmental Fate / Exposure Summary\n\n\n                    Context: \n                    Section 12.2.2, \"Environmental Fate / Exposure Summary,\" provides an overview of how meprobamate behaves in the environment following its production, use, and potential release. This section fits within the broader \"Toxicity\" and \"Ecological Information\" parts of the document, summarizing the environmental persistence, potential transport routes (air, water, soil), degradation, and possible pathways for human and ecological exposure to meprobamate. It connects chemical and physical properties with environmental and public health risk assessments.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_95", "document_index": 50, "latency_s": 58.82420110001112, "prompt_toks": 28448, "completion_toks": 63}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprobamate's production and use as an antianxiety agent may result in its release to the environment through various waste streams. If released to air, an estimated vapor pressure of 3.0X10-3 mm Hg at 25 °C indicates meprobamate will exist solely as a vapor in the atmosphere. Vapor-phase meprobamate will be degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals; the half-life for this reaction in air is estimated to be 20 hrs. Meprobamate does not contain chromophores that absorb at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight. If released to soil, meprobamate is expected to high mobility based upon an estimated Koc of 60. Volatilization from moist soil surfaces is not expected to be an important fate process based upon an estimated Henry's Law constant of 1.8X10-10 atm-cu m/mole. Meprobamate may not volatilize from dry soil surfaces based upon its vapor pressure. Meprobamate has been classified\n\n\n                    Context: \n                    This passage appears in the section titled \"Ecological Information,\" specifically under \"Environmental Fate / Exposure Summary.\" It describes the environmental fate of meprobamate after its production or use, detailing its behavior and degradation in air, soil, and water, including estimates of volatility, mobility, degradation pathways, and persistence.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_96", "document_index": 50, "latency_s": 53.1711767000088, "prompt_toks": 28421, "completion_toks": 88}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    process based upon an estimated Henry's Law constant of 1.8X10-10 atm-cu m/mole. Meprobamate may not volatilize from dry soil surfaces based upon its vapor pressure. Meprobamate has been classified as non-biodegradable. If released into water, meprobamate is not expected to adsorb to suspended solids and sediment based upon the estimated Koc. Volatilization from water surfaces is not expected to be an important fate process based upon this compound's estimated Henry's Law constant. An estimated BCF of 3 suggests the potential for bioconcentration in aquatic organisms is low. Hydrolysis is not expected to be an important environmental fate process since this compound lacks functional groups that hydrolyze under environmental conditions. Occupational exposure to meprobamate may occur through inhalation and dermal contact with this compound at workplaces where meprobamate is produced or used. Monitoring data indicate that the general population may be exposed to meprobamate via\n\n\n                    Context: \n                    This passage comes from the environmental fate section of the full Meprobamate compound profile, summarizing its physical-chemical behavior in soil and water, volatilization potential, biodegradability, bioaccumulation risk, persistence, and typical routes of occupational and general population exposure. It is part of a broader discussion on ecological impact and human exposure pathways within the detailed safety, toxicity, and regulatory information for Meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_97", "document_index": 50, "latency_s": 54.28071820002515, "prompt_toks": 28307, "completion_toks": 68}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    through inhalation and dermal contact with this compound at workplaces where meprobamate is produced or used. Monitoring data indicate that the general population may be exposed to meprobamate via inhalation or ingestion of contaminated drinking water, and dermal contact with this compound or other consumer products containing meprobamate. Exposure to meprobamate among the general population may also be due to those administered the drug, an anxiolytic. (SRC)\n\n\n                    Context: \n                    This excerpt is from the section detailing the probable routes of human exposure to meprobamate, describing how both occupational (inhalation and skin contact in workplaces) and general population exposure (via air, water, skin contact, or medical use) can occur, as part of the broader toxicological and environmental fate information about the compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_98", "document_index": 50, "latency_s": 56.70668730000034, "prompt_toks": 28304, "completion_toks": 81}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    12.2.3 Artificial Pollution Sources\n\nMeprobamate's production and use as an antianxiety agent(1) may result in its release to the environment through various waste streams(SRC).\n\n(1) Lewis RJ, Sr; Hawley's Condensed Chemical Dictionary. 15th ed. John Wiley & Sons, Inc. New York, NY p. 798 (2007)\n\n12.2.4 Environmental Fate\n\n\n                    Context: \n                    This section discusses the environmental impact and behavior of meprobamate, specifically potential sources of environmental pollution from its manufacture and use as an antianxiety drug. It follows preceding sections on toxicity and precedes detailed information about the environmental fate, persistence, and transport of meprobamate in soil, water, and air, thereby supporting users seeking information on the environmental risks and pathways associated with pharmaceutical contaminants.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_99", "document_index": 50, "latency_s": 54.89871780000976, "prompt_toks": 28477, "completion_toks": 106}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (1) Lewis RJ, Sr; Hawley's Condensed Chemical Dictionary. 15th ed. John Wiley & Sons, Inc. New York, NY p. 798 (2007)\n\n12.2.4 Environmental Fate\n\nTERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 60(SRC), determined from a log Kow of 0.70(2) and a regression-derived equation(3), indicates that meprobamate is expected to have high mobility in soil(SRC). Volatilization of meprobamate from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 1.8X10-10 atm-cu m/mole(SRC), using a fragment constant estimation method(4). Meprobamate is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 3.0X10-3 mm Hg at 25 °C(SRC), determined from a fragment constant method(5). Meprobamate has been classified as non-biodegradable(6).\n\n(1) Swann RL et al; Res Rev 85: 17-28 (1983)\n\n\n                    Context: \n                    This chunk appears in the \"Environmental Fate\" section of the Meprobamate compound page, detailing how meprobamate behaves in terrestrial environments after environmental release. It discusses its soil mobility, potential for volatilization from soil surfaces, and biodegradability, supported by estimations and reference data. This information is part of the broader \"Ecological Information\" and \"Toxicity\" sections, which address the environmental impact, persistence, and movement of meprobamate outside of clinical and pharmacological contexts.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_100", "document_index": 50, "latency_s": 55.27192069997545, "prompt_toks": 28417, "completion_toks": 69}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (1) Swann RL et al; Res Rev 85: 17-28 (1983)\n\n(2) Hansch C et al; Exploring QSAR. Hydrophobic, Electronic, and Steric Constants. ACS Prof Ref Book. Heller SR, consult. ed., Washington, DC: Amer Chem Soc p. 65 (1995)\n\n(3) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 4-9 (1990)\n\n(4) Meylan WM, Howard PH; Environ Toxicol Chem 10: 1283-93 (1991)\n\n(5) Lyman WJ; p. 31 in Environmental Exposure From Chemicals Vol I, Neely WB, Blau GE, eds, Boca Raton, FL: CRC Press (1985)\n\n(6) Richardson ML, Bowman JM; J Pharm Pharmacol 37: 1-12 (1985)\n\n\n                    Context: \n                    This chunk is a list of references cited in the sections discussing meprobamate’s environmental fate, particularly its mobility in soil, adsorption, biodegradability, and other physicochemical properties affecting environmental behavior. These references support data in the document’s “Ecological Information” and “Environmental Fate/Exposure Summary” subsections.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_101", "document_index": 50, "latency_s": 57.33997739999904, "prompt_toks": 28483, "completion_toks": 135}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (5) Lyman WJ; p. 31 in Environmental Exposure From Chemicals Vol I, Neely WB, Blau GE, eds, Boca Raton, FL: CRC Press (1985)\n\n(6) Richardson ML, Bowman JM; J Pharm Pharmacol 37: 1-12 (1985)\n\nAQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 60(SRC), determined from a log Kow of 0.70(2) and a regression-derived equation(3), indicates that meprobamate is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 1.8X10-10 atm-cu m/mole(SRC), developed using a fragment constant estimation method(4). According to a classification scheme(5), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(6), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Meprobamate has been classified as non-biodegradable(7).\n\n(1) Swann RL et al; Res Rev 85: 17-28 (1983)\n\n\n                    Context: \n                    This chunk appears in the section detailing the environmental fate and behavior of meprobamate, specifically discussing its mobility in aquatic systems. It summarizes studies and estimations on sorption (Koc), volatilization potential (Henry's Law constant), bioconcentration factor (BCF), and biodegradability, highlighting that meprobamate is highly mobile in water, not prone to sediment adsorption, unlikely to volatilize, has low potential for bioaccumulation, and is classified as non-biodegradable. This contextualizes meprobamate's persistence and transport in aquatic environments within the document’s broader assessment of its environmental impact and exposure pathways.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_102", "document_index": 50, "latency_s": 54.17992600001162, "prompt_toks": 28433, "completion_toks": 59}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (1) Swann RL et al; Res Rev 85: 17-28 (1983)\n\n(2) Hansch C et al; Exploring QSAR. Hydrophobic, Electronic, and Steric Constants. ACS Prof Ref Book. Heller SR, consult. ed., Washington, DC: Amer Chem Soc p. 65 (1995)\n\n(3) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 4-9, 15-1 to 15-29 (1990)\n\n(4) Meylan WM, Howard PH; Environ Toxicol Chem 10: 1283-93 (1991)\n\n(5) Franke C et al; Chemosphere 29: 1501-14 (1994)\n\n(6) Meylan WM et al; Environ Toxicol Chem 18: 664-72 (1999)\n\n(7) Richardson ML, Bowman JM; J Pharm Pharmacol 37: 1-12 (1985)\n\n\n                    Context: \n                    This chunk is a list of scientific references supporting the environmental fate and behavior of meprobamate, specifically regarding its soil adsorption/mobility, aquatic fate, bioconcentration, and biodegradation properties, found within the section detailing the compound's environmental fate and ecotoxicological assessment.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_103", "document_index": 50, "latency_s": 55.93202310000197, "prompt_toks": 28490, "completion_toks": 91}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (5) Franke C et al; Chemosphere 29: 1501-14 (1994)\n\n(6) Meylan WM et al; Environ Toxicol Chem 18: 664-72 (1999)\n\n(7) Richardson ML, Bowman JM; J Pharm Pharmacol 37: 1-12 (1985)\n\nATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), meprobamate, which has an estimated vapor pressure of 3.0X10-3 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely as a vapor in the ambient atmosphere. Vapor-phase meprobamate is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 20 hours(SRC), calculated from its rate constant of 1.9X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Meprobamate does not contain chromophores that absorb at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).\n\n\n                    Context: \n                    This chunk is part of the \"Environmental Fate\" section under \"Ecological Information,\" describing the atmospheric behavior of meprobamate. It details how meprobamate exists as a vapor in air, is degraded by hydroxyl radicals with an estimated half-life of 20 hours, and is resistant to direct photolysis due to its chemical structure. This information helps assess meprobamate’s persistence and transformation in the atmosphere following environmental release.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_104", "document_index": 50, "latency_s": 56.94263409997802, "prompt_toks": 28414, "completion_toks": 61}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (1) Bidleman TF; Environ Sci Technol 22: 361-367 (1988)\n\n(2) Lyman WJ; p. 31 in Environmental Exposure From Chemicals Vol I, Neely WB, Blau GE, eds, Boca Raton, FL: CRC Press (1985)\n\n(3) Meylan WM, Howard PH; Chemosphere 26: 2293-99 (1993)\n\n(4) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 8-12 (1990)\n\n12.2.5 Environmental Biodegradation\n\nAEROBIC: Meprobamate has been classified as non-biodegradable(1).\n\nPMID:2858520\n\n(1) Richardson ML, Bowman JM; J Pharm Pharmacol 37: 1-12 (1985)\n\n12.2.6 Environmental Abiotic Degradation\n\n\n                    Context: \n                    This section is part of the Environmental Fate and Ecological Information for meprobamate, detailing its environmental biodegradation and abiotic degradation. It follows references about atmospheric fate and precedes specifics on abiotic degradation processes, providing key information about meprobamate's persistence and breakdown in the environment.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_105", "document_index": 50, "latency_s": 55.66248900000937, "prompt_toks": 28461, "completion_toks": 92}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    AEROBIC: Meprobamate has been classified as non-biodegradable(1).\n\nPMID:2858520\n\n(1) Richardson ML, Bowman JM; J Pharm Pharmacol 37: 1-12 (1985)\n\n12.2.6 Environmental Abiotic Degradation\n\nThe rate constant for the vapor-phase reaction of meprobamate with photochemically-produced hydroxyl radicals has been estimated as 1.9X10-11 cu cm/molecule-sec at 25 °C(SRC) using a structure estimation method(1). This corresponds to an atmospheric half-life of about 20 hours at an atmospheric concentration of 5X10+5 hydroxyl radicals per cu cm(1). Meprobamate is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(2). Meprobamate does not contain chromophores that absorb at wavelengths >290 nm(2) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC).\n\n(1) Meylan WM, Howard PH; Chemosphere 26: 2293-99 (1993)\n\n\n                    Context: \n                    This section is part of the environmental fate and degradation discussion for meprobamate, specifically summarizing its persistence in the environment. It reports that meprobamate is classified as non-biodegradable under aerobic conditions and describes its limited abiotic degradation, including slow atmospheric breakdown via hydroxyl radicals and resistance to hydrolysis and photolysis. This information is located within the broader toxicity and environmental impact assessment of meprobamate in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_106", "document_index": 50, "latency_s": 56.07559069999843, "prompt_toks": 28472, "completion_toks": 86}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (1) Meylan WM, Howard PH; Chemosphere 26: 2293-99 (1993)\n\n(2) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 7-4, 7-5, 8-12 (1990)\n\n12.2.7 Environmental Bioconcentration\n\nAn estimated BCF of 3 was calculated in fish for meprobamate(SRC), using a log Kow of 0.70(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC).\n\n(1) Hansch C et al; Exploring QSAR. Hydrophobic, Electronic, and Steric Constants. ACS Prof Ref Book. Heller SR, consult. ed., Washington, DC: Amer Chem Soc p. 65 (1995)\n\n(2) Meylan WM et al; Environ Toxicol Chem 18: 664-72 (1999)\n\n(3) Franke C et al; Chemosphere 29: 1501-14 (1994)\n\n12.2.8 Soil Adsorption / Mobility\n\n\n                    Context: \n                    This section is part of the document's detailed analysis of the environmental fate and ecotoxicological properties of meprobamate. It presents data on the compound's potential for bioconcentration in aquatic organisms, specifically reporting a low estimated bioconcentration factor (BCF), and then transitions into its mobility in soil. This context is within the broader ecological and environmental impact assessment following sections on human toxicity, exposure, and regulatory information.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_107", "document_index": 50, "latency_s": 54.10485570001765, "prompt_toks": 28462, "completion_toks": 83}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (2) Meylan WM et al; Environ Toxicol Chem 18: 664-72 (1999)\n\n(3) Franke C et al; Chemosphere 29: 1501-14 (1994)\n\n12.2.8 Soil Adsorption / Mobility\n\nThe Koc of meprobamate is estimated as 60(SRC), using a log Kow of 0.70(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that meprobamate is expected to have high mobility in soil.\n\n(1) Hansch C et al; Exploring QSAR. Hydrophobic, Electronic, and Steric Constants. ACS Prof Ref Book. Heller SR, consult. ed., Washington, DC: Amer Chem Soc p. 65 (1995)\n\n(2) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 4-9 (1990)\n\n(3) Swann RL et al; Res Rev 85: 17-28 (1983)\n\n12.2.9 Volatilization from Water / Soil\n\n\n                    Context: \n                    This section is part of the \"Ecological Information\" chapter, specifically addressing meprobamate's environmental behavior. It provides data on the compound's estimated soil adsorption coefficient (Koc), predicting high mobility in soil, based on its log Kow value and referenced estimation methods. The context is environmental fate and transport, relevant for assessing meprobamate's potential movement through soil and risk of groundwater contamination.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_108", "document_index": 50, "latency_s": 58.749106400005985, "prompt_toks": 28504, "completion_toks": 102}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (3) Swann RL et al; Res Rev 85: 17-28 (1983)\n\n12.2.9 Volatilization from Water / Soil\n\nThe Henry's Law constant for meprobamate is estimated as 1.8X10-10 atm-cu m/mole(SRC) using a fragment constant estimation method(1). This Henry's Law constant indicates that meprobamate is expected to be essentially nonvolatile from water surfaces(2). Meprobamate is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 3.0X10-3 mm Hg(SRC), determined from a fragment constant method(3).\n\n(1) Meylan WM, Howard PH; Environ Toxicol Chem 10: 1283-93 (1991)\n\n(2) Lyman WJ; p. 31 in Environmental Exposure From Chemicals Vol I, Neely WB, Blau GE, eds, Boca Raton, FL: CRC Press (1985)\n\n12.2.10 Environmental Water Concentrations\n\nGROUNDWATER: Meprobamate was detected not quantified in groundwater samples collected from the Hipps Road Landfill, Jacksonville, Duval County, Florida in 1984(1).\n\n(1) Eckel WP et al; Ground Water 31: 801-4 (1993)\n\n\n                    Context: \n                    This section appears in the Ecological Information part of the Meprobamate compound page, specifically under environmental fate and transport. It discusses the physicochemical property of volatilization, presenting the estimated Henry's Law constant and its implication—meprobamate is essentially nonvolatile from water and soil surfaces. It then transitions to environmental monitoring data, noting the detection (but not quantification) of meprobamate in groundwater at a Florida landfill, thus linking predicted environmental behavior with real-world occurrence.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_109", "document_index": 50, "latency_s": 53.66663640001207, "prompt_toks": 28494, "completion_toks": 91}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (1) Eckel WP et al; Ground Water 31: 801-4 (1993)\n\nSURFACE WATER: Meprobamate was detected, not quantified in the Las Vegas Bay of Lake Mead (Hoover Dam impoundment on the Colorado River), NV, sampled during 1998-1999(1).\n\n(1) Snyder SA et al; in Amer Chem Soc, ACS Symp Ser, 791(Pharmaceuticals and Personal Care Products in the Environment): 116-141 (2001)\n\n12.2.11 Milk Concentrations\n\nEXPERIMENTAL: Meprobamate is excreted in /human/ breast milk and should not be given to lactating mothers.\n\nEllenhorn, M.J. and D.G. Barceloux. Medical Toxicology - Diagnosis and Treatment of Human Poisoning. New York, NY: Elsevier Science Publishing Co., Inc. 1988., p. 594\n\nEXPERIMENTAL: Meprobamate is distributed into the milk of lactating women in a concentration 2-4 times that in plasma.\n\nMcEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1992 (Plus Supplements 1992)., p. 1370\n\n\n                    Context: \n                    This section presents data on meprobamate's occurrence in the environment and its excretion in breast milk. It reports environmental monitoring findings of meprobamate detected in groundwater and surface water, as well as experimental evidence that meprobamate is excreted into human breast milk at concentrations higher than in plasma. This information is part of the document's broader discussion on the environmental fate, human exposure, and body burden of meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_110", "document_index": 50, "latency_s": 55.303656000003684, "prompt_toks": 28423, "completion_toks": 84}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1992 (Plus Supplements 1992)., p. 1370\n\n12.2.12 Probable Routes of Human Exposure\n\nNIOSH (NOES Survey 1981-1983) has statistically estimated that 2,046 workers (1,000 of these were female) were potentially exposed to meprobamate in the US(1). Occupational exposure to meprobamate may occur through inhalation and dermal contact with this compound at workplaces where meprobamate is produced or used. Monitoring data indicate that the general population may be exposed to meprobamate via inhalation or ingestion of contaminated drinking water, and dermal contact with this compound or other consumer products containing meprobamate. Exposure to meprobamate among the general population may also be due to those administered the drug, an anxiolytic(SRC).\n\n\n                    Context: \n                    This section is part of the document's broader analysis of meprobamate's toxicity and environmental impact, specifically detailing the potential routes by which humans may be exposed to meprobamate, including occupational, environmental, and pharmaceutical sources. It follows the discussion on milk concentrations and is within the \"Ecological Information\" and \"Toxicity\" sections, providing insight into exposure pathways relevant for risk assessment and regulatory considerations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_111", "document_index": 50, "latency_s": 55.602994199987734, "prompt_toks": 28448, "completion_toks": 74}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    (1) NIOSH; NOES. National Occupational Exposure Survey conducted from 1981-1983. Estimated numbers of employees potentially exposed to specific agents by 2-digit standard industrial classification (SIC). Available from https://www.cdc.gov/noes/ as of Apr 23, 2009.\n\n12.2.13 Body Burden\n\nMeprobamate crosses the placenta; the maternal blood meprobamate levels approximate those of the fetus. Meprobamate is excreted in breast milk and should not be given to lactating mothers. An epidemiologic study of the use of meprobamate in pregnancy (1,870 offspring) did not reveal any increased evidence of fetal demise or abnormalities when these children were studied until 4 years of age.\n\nEllenhorn, M.J. and D.G. Barceloux. Medical Toxicology - Diagnosis and Treatment of Human Poisoning. New York, NY: Elsevier Science Publishing Co., Inc. 1988., p. 594\n\nMeprobamate is distributed into the milk of lactating women in a concentration 2-4 times that in plasma.\n\n\n                    Context: \n                    This section is part of the comprehensive toxicological and exposure profile for meprobamate, specifically addressing its distribution in the human body, placental transfer, breast milk excretion, and findings from epidemiological studies regarding fetal and infant risk. It follows preceding environmental exposure and fate information and provides critical data on maternal and fetal body burden relevant for risk assessment and regulatory review.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_112", "document_index": 50, "latency_s": 56.04458970000269, "prompt_toks": 28472, "completion_toks": 78}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprobamate is distributed into the milk of lactating women in a concentration 2-4 times that in plasma.\n\nMcEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 92. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1992 (Plus Supplements 1992)., p. 1370\n\n13 Associated Disorders and Diseases\n\n14 Literature\n\n14.1 Consolidated References\n\n14.2 NLM Curated PubMed Citations\n\n14.3 Springer Nature References\n\n14.4 Thieme References\n\n14.5 Chemical Co-Occurrences in Literature\n\n14.6 Chemical-Gene Co-Occurrences in Literature\n\n14.7 Chemical-Disease Co-Occurrences in Literature\n\n15 Patents\n\nUS6649659\n\nUS4981874\n\nCA2152615\n\nCA1336266\n\n15.1 Depositor-Supplied Patent Identifiers\n\nLink to all deposited patent identifiers\n\n15.2 WIPO PATENTSCOPE\n\nPatents are available for this chemical structure:\n\nhttps://patentscope.wipo.int/search/en/result.jsf?inchikey=NPPQSCRMBWNHMW-UHFFFAOYSA-N\n\n15.3 Chemical Co-Occurrences in Patents\n\n\n                    Context: \n                    This chunk appears near the end of the document, summarizing findings about meprobamate's excretion into breast milk at concentrations 2-4 times higher than plasma, followed by sections on associated disorders, a comprehensive literature review including references and curated citations, and patent information relevant to meprobamate. It connects clinical pharmacokinetics to subsequent resources for further research and regulatory details.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_113", "document_index": 50, "latency_s": 57.30538649999653, "prompt_toks": 28501, "completion_toks": 107}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Patents are available for this chemical structure:\n\nhttps://patentscope.wipo.int/search/en/result.jsf?inchikey=NPPQSCRMBWNHMW-UHFFFAOYSA-N\n\n15.3 Chemical Co-Occurrences in Patents\n\n15.4 Chemical-Disease Co-Occurrences in Patents\n\n15.5 Chemical-Gene Co-Occurrences in Patents\n\n16 Interactions and Pathways\n\n16.1 Chemical-Target Interactions\n\n16.2 Drug-Drug Interactions\n\n16.3 Drug-Food Interactions\n\nAvoid alcohol.\n\nTake with or without food. Food does not significantly affect absorption.\n\n16.4 Pathways\n\n17 Biological Test Results\n\n17.1 BioAssay Results\n\n18 Classification\n\n18.1 MeSH Tree\n\n18.2 NCI Thesaurus Tree\n\n18.3 ChEBI Ontology\n\n18.4 KEGG: USP\n\n18.5 KEGG: ATC\n\n18.6 KEGG: Target-based Classification of Drugs\n\n18.7 KEGG: Drug Groups\n\n18.8 WHO ATC Classification System\n\n18.9 ChemIDplus\n\n18.10 CAMEO Chemicals\n\n18.11 ChEMBL Target Tree\n\n18.12 UN GHS Classification\n\n18.13 Drug Enforcement Administration (DEA) Classification\n\n18.14 NORMAN Suspect List Exchange Classification\n\n\n                    Context: \n                    This section appears in the latter part of the Meprobamate compound page, following information on patents related to meprobamate. It continues with discussions of the compound's interactions and biological pathways, outlining chemical-target, drug-drug, and drug-food interactions (such as the recommendation to avoid alcohol), as well as associated metabolic and biological pathways. Subsequent sections provide brief listings of bioassay results and detail various classification systems in which meprobamate is categorized, including medical, chemical, regulatory, and pharmacological frameworks.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_114", "document_index": 50, "latency_s": 55.462537499988684, "prompt_toks": 28401, "completion_toks": 90}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    18.10 CAMEO Chemicals\n\n18.11 ChEMBL Target Tree\n\n18.12 UN GHS Classification\n\n18.13 Drug Enforcement Administration (DEA) Classification\n\n18.14 NORMAN Suspect List Exchange Classification\n\n18.15 EPA DSSTox Classification\n\n18.16 EPA TSCA and CDR Classification\n\n18.17 FDA Drug Type and Pharmacologic Classification\n\n18.18 EPA Substance Registry Services Tree\n\n18.19 MolGenie Organic Chemistry Ontology\n\n18.20 Chemicals in PubChem from Regulatory Sources\n\n19 Information Sources\n\nAustralian Industrial Chemicals Introduction Scheme (AICIS)\n\nLICENSE\n\nhttps://www.industrialchemicals.gov.au/copyright\n\n1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate\n\nhttps://services.industrialchemicals.gov.au/search-assessments/\n\nCAMEO Chemicals\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears near the end of the document, within the \"Classification\" section. It lists various classification systems and regulatory databases (such as CAMEO Chemicals, ChEMBL, DEA, EPA, FDA, MolGenie, etc.) that categorize or provide regulatory information on meprobamate. This is immediately followed by the \"Information Sources\" section, which provides licensing information and direct links to source databases referenced throughout the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_115", "document_index": 50, "latency_s": 54.33559740000055, "prompt_toks": 28458, "completion_toks": 77}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LICENSE\n\nhttps://www.industrialchemicals.gov.au/copyright\n\n1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate\n\nhttps://services.industrialchemicals.gov.au/search-assessments/\n\nCAMEO Chemicals\n\nLICENSE\n\nCAMEO Chemicals and all other CAMEO products are available at no charge to those organizations and individuals (recipients) responsible for the safe handling of chemicals. However, some of the chemical data itself is subject to the copyright restrictions of the companies or organizations that provided the data.\n\nhttps://cameochemicals.noaa.gov/help/reference/terms_and_conditions.htm?d_f=false\n\nMEPROBAMATE\n\nhttps://cameochemicals.noaa.gov/chemical/20592\n\nCAMEO Chemical Reactivity Classification\n\nhttps://cameochemicals.noaa.gov/browse/react\n\nCAS Common Chemistry\n\nLICENSE\n\nThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.\n\nhttps://creativecommons.org/licenses/by-nc/4.0/\n\nMeprobamate\n\nhttps://commonchemistry.cas.org/detail?cas_rn=57-53-4\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section listing external databases and resources related to meprobamate, including licensing terms and direct links to chemical records and regulatory assessments from agencies such as AICIS, CAMEO Chemicals, and CAS Common Chemistry. It provides authoritative sources for further information about meprobamate's properties, safety, regulation, and chemical identity.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_116", "document_index": 50, "latency_s": 59.50145540002268, "prompt_toks": 28484, "completion_toks": 89}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://creativecommons.org/licenses/by-nc/4.0/\n\nMeprobamate\n\nhttps://commonchemistry.cas.org/detail?cas_rn=57-53-4\n\nChemIDplus\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nMeprobamate [USP:INN:BAN:JAN]\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000057534\n\nChemIDplus Chemical Information Classification\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/chemidplus\n\nDrugBank\n\nLICENSE\n\nCreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)\n\nhttps://www.drugbank.ca/legal/terms_of_use\n\nMeprobamate\n\nhttps://www.drugbank.ca/drugs/DB00371\n\nDTP/NCI\n\nLICENSE\n\nUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.\n\nhttps://www.cancer.gov/policies/copyright-reuse\n\nmeprobamate\n\nhttps://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=30418\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, listing external databases and resources containing information on Meprobamate. It provides licensing information and direct links to Meprobamate entries in databases such as CAS Common Chemistry, ChemIDplus, DrugBank, and the National Cancer Institute (DTP/NCI), helping users locate authoritative chemical, pharmacological, and toxicological data beyond the main document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_117", "document_index": 50, "latency_s": 52.433483600005275, "prompt_toks": 28435, "completion_toks": 73}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.cancer.gov/policies/copyright-reuse\n\nmeprobamate\n\nhttps://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=30418\n\nEPA Chemicals under the TSCA\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\n1,3-Propanediol, 2-methyl-2-propyl-, 1,3-dicarbamate\n\nhttps://www.epa.gov/chemicals-under-tsca\n\nEPA TSCA Classification\n\nhttps://www.epa.gov/tsca-inventory\n\nEPA DSSTox\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\nMeprobamate\n\nhttps://comptox.epa.gov/dashboard/DTXSID3023261\n\nCompTox Chemicals Dashboard Chemical Lists\n\nhttps://comptox.epa.gov/dashboard/chemical-lists/\n\nEuropean Chemicals Agency (ECHA)\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section near the end of the document, listing data providers, copyright notices, and authoritative links related to meprobamate in chemical and regulatory databases, including the EPA, NCI, and ECHA. It is part of a comprehensive directory of external resources and legal information supporting the chemical data presented elsewhere in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_118", "document_index": 50, "latency_s": 55.88829390000319, "prompt_toks": 28415, "completion_toks": 72}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Meprobamate\n\nhttps://comptox.epa.gov/dashboard/DTXSID3023261\n\nCompTox Chemicals Dashboard Chemical Lists\n\nhttps://comptox.epa.gov/dashboard/chemical-lists/\n\nEuropean Chemicals Agency (ECHA)\n\nLICENSE\n\nUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section of the document, listing authoritative regulatory and chemical databases relevant to Meprobamate—specifically, the EPA's CompTox Chemicals Dashboard and the European Chemicals Agency (ECHA)—along with licensing terms. It provides references for further regulatory, safety, and chemical information on Meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_119", "document_index": 50, "latency_s": 57.229146999976365, "prompt_toks": 28473, "completion_toks": 87}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://echa.europa.eu/web/guest/legal-notice\n\nMeprobamate\n\nhttps://echa.europa.eu/substance-information/-/substanceinfo/100.000.306\n\nMeprobamate (EC: 200-337-5)\n\nhttps://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/44995\n\nFDA Global Substance Registration System (GSRS)\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nMEPROBAMATE\n\nhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/9I7LNY769Q\n\nHazardous Substances Data Bank (HSDB)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/web_policies.html\n\nMEPROBAMATE\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/hsdb/3117\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section, listing key databases and regulatory resources related to Meprobamate, including external links to the European Chemicals Agency (ECHA), FDA Global Substance Registration System (GSRS), and the Hazardous Substances Data Bank (HSDB), along with their respective licensing information. It helps users locate authoritative regulatory, safety, and chemical information on Meprobamate from official organizations.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_120", "document_index": 50, "latency_s": 55.73950570001034, "prompt_toks": 28439, "completion_toks": 69}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Hazardous Substances Data Bank (HSDB)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/web_policies.html\n\nMEPROBAMATE\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/hsdb/3117\n\nHuman Metabolome Database (HMDB)\n\nLICENSE\n\nHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.\n\nhttp://www.hmdb.ca/citing\n\nMeprobamate\n\nhttp://www.hmdb.ca/metabolites/HMDB0014515\n\nHMDB0014515_cms_27629\n\nhttps://hmdb.ca/metabolites/HMDB0014515#spectra\n\nNew Zealand Environmental Protection Authority (EPA)\n\nLICENSE\n\nThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.\n\n\n                    Context: \n                    This chunk is part of the references and information sources section at the end of the Meprobamate compound page, listing external databases and resources—such as HSDB, HMDB, and New Zealand EPA—that provide additional data, licensing terms, and links related to Meprobamate's chemical properties, safety, metabolism, and regulatory information.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_121", "document_index": 50, "latency_s": 55.50510619999841, "prompt_toks": 28483, "completion_toks": 75}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    New Zealand Environmental Protection Authority (EPA)\n\nLICENSE\n\nThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.\n\nhttps://www.epa.govt.nz/about-this-site/general-copyright-statement/\n\n1,3-Propanediol, 2-methyl-2-propyl-, dicarbamate\n\nhttps://www.epa.govt.nz/industry-areas/hazardous-substances/guidance-for-importers-and-manufacturers/hazardous-substances-databases/\n\nUSDA APHIS Chemical Effects Database\n\nLICENSE\n\nhttps://www.aphis.usda.gov/freedom-information-act\n\nEquanil\n\nhttps://www.aphis.usda.gov/ws/nwrc/chem-effects-db/nwrcToxicology_Browse.html\n\nCalifornia Office of Environmental Health Hazard Assessment (OEHHA)\n\nMeprobamate\n\nhttps://oehha.ca.gov/proposition-65/chemicals/meprobamate\n\nChEBI\n\nMeprobamate\n\nhttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6761\n\nChEBI Ontology\n\nhttp://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology\n\nDrug Enforcement Administration (DEA)\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section near the end of the document, listing external databases, regulatory agencies, and authoritative resources related to meprobamate. It provides source names, licensing information, and direct links to relevant substance entries or regulatory guidance, supporting the compilation and verification of the chemical, toxicological, and regulatory data presented earlier in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_122", "document_index": 50, "latency_s": 55.05210510001052, "prompt_toks": 28447, "completion_toks": 89}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:6761\n\nChEBI Ontology\n\nhttp://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology\n\nDrug Enforcement Administration (DEA)\n\nLICENSE\n\nUnless otherwise indicated, information on Department of Justice websites is in the public domain and may be copied and distributed without permission. Citation of the Department of Justice as source of the information is appreciated, as appropriate.\n\nhttps://www.justice.gov/legalpolicies\n\nMeprobamate\n\nhttps://www.deadiversion.usdoj.gov/schedules/\n\nDEA Drug and Chemical Classification\n\nhttps://www.dea.gov/drug-information/drug-scheduling\n\nLiverTox\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nMeprobamate\n\nhttps://www.ncbi.nlm.nih.gov/books/n/livertox/Meprobamate/\n\nNCI Thesaurus (NCIt)\n\nLICENSE\n\nUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section near the end of the document, listing databases and regulatory resources relevant to Meprobamate. It includes external links to chemical, regulatory, and toxicological databases such as ChEBI, DEA, LiverTox, and the NCI Thesaurus, alongside licensing terms and usage notes for each resource. This section serves as a reference hub for further authoritative information on Meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_123", "document_index": 50, "latency_s": 55.670267699984834, "prompt_toks": 28438, "completion_toks": 75}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LICENSE\n\nUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.\n\nhttps://www.cancer.gov/policies/copyright-reuse\n\nhttps://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C47603\n\nNCI Thesaurus\n\nhttps://ncit.nci.nih.gov\n\nOpen Targets\n\nLICENSE\n\nDatasets generated by the Open Targets Platform are freely available for download.\n\nhttps://platform-docs.opentargets.org/licence\n\nMEPROBAMATE\n\nhttps://platform.opentargets.org/drug/CHEMBL979\n\nCalifornia Safe Cosmetics Program (CSCP) Product Database\n\nLICENSE\n\nhttps://www.cdph.ca.gov/Pages/Conditions-of-Use.aspx\n\nMeprobamate\n\nhttps://www.cdph.ca.gov/Programs/CCDPHP/DEODC/OHB/CSCP/Pages/About-CSCP.aspx\n\nChEMBL\n\nLICENSE\n\n\n                    Context: \n                    This chunk is from the \"Information Sources\" section listing external databases and resources related to meprobamate. It provides license information, official database links, and references to authoritative sources such as the NCI Thesaurus, Open Targets, California Safe Cosmetics Program, and ChEMBL, enabling users to access further data and reuse terms subject to respective terms of use.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_124", "document_index": 50, "latency_s": 55.54769210002269, "prompt_toks": 28481, "completion_toks": 86}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LICENSE\n\nhttps://www.cdph.ca.gov/Pages/Conditions-of-Use.aspx\n\nMeprobamate\n\nhttps://www.cdph.ca.gov/Programs/CCDPHP/DEODC/OHB/CSCP/Pages/About-CSCP.aspx\n\nChEMBL\n\nLICENSE\n\nAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).\n\nhttp://www.ebi.ac.uk/Information/termsofuse.html\n\nhttps://www.ebi.ac.uk/chembl/explore/compound/CHEMBL979\n\nChEMBL Protein Target Tree\n\nhttps://www.ebi.ac.uk/chembl/g/#browse/targets\n\nComparative Toxicogenomics Database (CTD)\n\nLICENSE\n\nIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.\n\nhttp://ctdbase.org/about/legal.jsp\n\nMeprobamate\n\nhttps://ctdbase.org/detail.go?type=chem&acc=D008620\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, listing external databases and resources related to Meprobamate. It provides links, licensing information, and brief descriptions for authoritative chemical and biomedical databases like the California Safe Cosmetics Program, ChEMBL, and the Comparative Toxicogenomics Database (CTD), helping users locate further regulatory, chemical, and biological data on Meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_125", "document_index": 50, "latency_s": 54.968343599990476, "prompt_toks": 28407, "completion_toks": 83}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    http://ctdbase.org/about/legal.jsp\n\nMeprobamate\n\nhttps://ctdbase.org/detail.go?type=chem&acc=D008620\n\nDrug Gene Interaction database (DGIdb)\n\nLICENSE\n\nThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.\n\nhttp://www.dgidb.org/downloads\n\nMEPROBAMATE\n\nhttps://www.dgidb.org/drugs/rxcui:6760\n\nTherapeutic Target Database (TTD)\n\nMeprobamate\n\nhttps://idrblab.net/ttd/data/drug/details/D0Y4AW\n\nDailyMed\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nMEPROBAMATE\n\nhttps://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=MEPROBAMATE\n\nNational Drug Code (NDC) Directory\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section, listing external databases and resources that provide data, identifiers, and further information on meprobamate. It specifically references the Comparative Toxicogenomics Database (CTD), Drug Gene Interaction database (DGIdb), Therapeutic Target Database (TTD), and DailyMed, including license terms and direct links to each database's entry for meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_126", "document_index": 50, "latency_s": 55.61116040000343, "prompt_toks": 28412, "completion_toks": 84}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    DailyMed\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nMEPROBAMATE\n\nhttps://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=MEPROBAMATE\n\nNational Drug Code (NDC) Directory\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nMEPROBAMATE\n\nhttps://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory\n\nDrug Induced Liver Injury Rank (DILIrank) Dataset\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears in the \"19 Information Sources\" section of the document, listing external databases and resources related to meprobamate. It provides links, licensing information, and brief descriptions for authoritative sources such as DailyMed, the FDA National Drug Code Directory, and the Drug Induced Liver Injury Rank (DILIrank) Dataset, supporting users seeking detailed drug, regulatory, and safety data on meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_127", "document_index": 50, "latency_s": 56.16331669999636, "prompt_toks": 28445, "completion_toks": 73}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    MEPROBAMATE\n\nhttps://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory\n\nDrug Induced Liver Injury Rank (DILIrank) Dataset\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nmeprobamate\n\nhttps://www.fda.gov/science-research/liver-toxicity-knowledge-base-ltkb/drug-induced-liver-injury-rank-dilirank-dataset\n\nDrugs and Lactation Database (LactMed)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nMeprobamate\n\nhttps://www.ncbi.nlm.nih.gov/books/n/lactmed/LM593/\n\nDrugs@FDA\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section, listing authoritative databases and resources related to meprobamate, including links to FDA drug directories, drug-induced liver injury datasets, lactation safety (LactMed), and official FDA drug information. It provides external references and licensing details for curated regulatory, safety, and clinical data on meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_128", "document_index": 50, "latency_s": 56.11715500001446, "prompt_toks": 28382, "completion_toks": 57}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Drugs and Lactation Database (LactMed)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nMeprobamate\n\nhttps://www.ncbi.nlm.nih.gov/books/n/lactmed/LM593/\n\nDrugs@FDA\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nMEPRIAM\n\nhttps://www.accessdata.fda.gov/scripts/cder/daf/\n\nFDA Orange Book\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the information sources and licensing section at the end of the document, listing database resources and copyright or usage terms relevant to meprobamate, including links to authoritative drug and regulatory databases such as LactMed, Drugs@FDA, and the FDA Orange Book.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_129", "document_index": 50, "latency_s": 55.03848940000171, "prompt_toks": 28471, "completion_toks": 73}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.fda.gov/about-fda/about-website/website-policies#linking\n\nMEPRIAM\n\nhttps://www.accessdata.fda.gov/scripts/cder/daf/\n\nFDA Orange Book\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nMEPROBAMATE\n\nhttps://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book\n\nNORMAN Suspect List Exchange\n\nLICENSE\n\nData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\nMeprobamate\n\nNORMAN Suspect List Exchange Classification\n\nhttps://www.norman-network.com/nds/SLE/\n\nMassBank Europe\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section near the end of the document, which lists external databases, regulatory authorities, and chemical information resources related to meprobamate. It details source names, licensing information, and relevant URLs for regulatory, drug approval, and chemical classification data, facilitating reference and verification for users seeking authoritative information on meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_130", "document_index": 50, "latency_s": 56.27265230001649, "prompt_toks": 28527, "completion_toks": 93}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://creativecommons.org/licenses/by/4.0/\n\nMeprobamate\n\nNORMAN Suspect List Exchange Classification\n\nhttps://www.norman-network.com/nds/SLE/\n\nMassBank Europe\n\nLICENSE\n\nhttps://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt\n\nMEPROBAMATE\n\nhttps://massbank.eu/MassBank/Result.jsp?inchikey=NPPQSCRMBWNHMW-UHFFFAOYSA-N\n\nMassBank of North America (MoNA)\n\nLICENSE\n\nThe content of the MoNA database is licensed under CC BY 4.0.\n\nhttps://mona.fiehnlab.ucdavis.edu/documentation/license\n\nMEPROBAMATE\n\nhttps://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27NPPQSCRMBWNHMW-UHFFFAOYSA-N%27)\n\nNIST Mass Spectrometry Data Center\n\nLICENSE\n\nData covered by the Standard Reference Data Act of 1968 as amended.\n\nhttps://www.nist.gov/srd/public-law\n\nMeprobamate\n\nhttp://www.nist.gov/srd/nist1a.cfm\n\nSpectraBase\n\nMeprobamate\n\nhttps://spectrabase.com/spectrum/2GOeP46aP7X\n\nCarisoprodol-M (dealkyl-) ##\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section of the Meprobamate PubChem page, listing databases and resources that provide chemical, spectral, and regulatory information for Meprobamate. It specifically cites external spectral databases (such as MassBank Europe, MoNA, NIST, and SpectraBase), their licensing terms, and direct links to Meprobamate's data entries or spectra, supporting data traceability and access to analytical reference material.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_131", "document_index": 50, "latency_s": 55.90683269998408, "prompt_toks": 28548, "completion_toks": 96}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.nist.gov/srd/public-law\n\nMeprobamate\n\nhttp://www.nist.gov/srd/nist1a.cfm\n\nSpectraBase\n\nMeprobamate\n\nhttps://spectrabase.com/spectrum/2GOeP46aP7X\n\nCarisoprodol-M (dealkyl-) ##\n\nhttps://spectrabase.com/spectrum/7inclEdsac2\n\nMeprobamate\n\nhttps://spectrabase.com/spectrum/GUa8hFkk5VS\n\nMeprobamate\n\nhttps://spectrabase.com/spectrum/BKK71Y7iOEW\n\nMEPROBAMATE;[2-(CARBAMOYLOXYMETHYL)-2-METHYL-PENTYL]-CARBAMATE\n\nhttps://spectrabase.com/spectrum/DQVa0ui2j8m\n\nMeprobamate\n\nhttps://spectrabase.com/spectrum/7q3n1sB11D9\n\nJapan Chemical Substance Dictionary (Nikkaji)\n\nhttp://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J4.475J\n\nKEGG\n\nLICENSE\n\nAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license\n\nhttps://www.kegg.jp/kegg/legal.html\n\nhttps://www.kegg.jp/entry/D00376\n\nUSP drug classification\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08302.keg\n\nAnatomical Therapeutic Chemical (ATC) classification\n\n\n                    Context: \n                    This chunk is from the \"Information Sources\" section of the Meprobamate compound webpage, listing external databases and resources that provide additional chemical, spectral, and regulatory information on Meprobamate. It includes references to NIST, SpectraBase, the Japan Chemical Substance Dictionary (Nikkaji), and KEGG, along with access links and licensing details. This section supports further research and data verification on Meprobamate by directing users to authoritative external data repositories.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_132", "document_index": 50, "latency_s": 55.43014579999726, "prompt_toks": 28476, "completion_toks": 76}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.kegg.jp/entry/D00376\n\nUSP drug classification\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08302.keg\n\nAnatomical Therapeutic Chemical (ATC) classification\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08303.keg\n\nTarget-based classification of drugs\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08310.keg\n\nDrug Groups\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08330.keg\n\nMetabolomics Workbench\n\nMeprobamate\n\nhttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=42739\n\nNLM RxNorm Terminology\n\nLICENSE\n\nThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.\n\nhttps://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html\n\nmeprobamate\n\n\n                    Context: \n                    This chunk appears in the references and sources section of the document, listing external databases and classification systems that include information on meprobamate, such as KEGG, USP drug classification, ATC classification, Metabolomics Workbench, and NLM RxNorm. These links provide pathways to additional chemical, pharmacological, and regulatory data related to meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_133", "document_index": 50, "latency_s": 57.939036900002975, "prompt_toks": 28472, "completion_toks": 88}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html\n\nmeprobamate\n\nhttps://rxnav.nlm.nih.gov/id/rxnorm/6760\n\nPharmGKB\n\nLICENSE\n\nPharmGKB data are subject to the Creative Commons Attribution-ShareALike 4.0 license (https://creativecommons.org/licenses/by-sa/4.0/).\n\nhttps://www.pharmgkb.org/page/policies\n\nmeprobamate\n\nhttps://www.pharmgkb.org/chemical/PA450377\n\nPharos\n\nLICENSE\n\nData accessed from Pharos and TCRD is publicly available from the primary sources listed above. Please respect their individual licenses regarding proper use and redistribution.\n\nhttps://pharos.nih.gov/about\n\nmeprobamate\n\nhttps://pharos.nih.gov/ligands/U8J1VCH94777\n\nSpringer Nature\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/341141182\n\nSpringerMaterials\n\n2-methyl-2-propyl-1,3-propanediyldicarbamate\n\nhttps://materials.springer.com/substanceprofile/docs/smsid_edsyavybiobbpqcv\n\nThieme Chemistry\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section that lists external databases, resources, and their licensing information relevant to meprobamate, including links to RxNorm, PharmGKB, Pharos, Springer Nature, SpringerMaterials, and Thieme Chemistry. It provides reference URLs and brief usage rights for each source, supporting further research and cross-referencing for chemical, pharmacological, and regulatory information on meprobamate.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_134", "document_index": 50, "latency_s": 54.126868299994385, "prompt_toks": 28460, "completion_toks": 68}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    SpringerMaterials\n\n2-methyl-2-propyl-1,3-propanediyldicarbamate\n\nhttps://materials.springer.com/substanceprofile/docs/smsid_edsyavybiobbpqcv\n\nThieme Chemistry\n\nLICENSE\n\nThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.\n\nhttps://creativecommons.org/licenses/by-nc-nd/4.0/\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/376883003\n\nUSGS Health-Based Screening Levels for Evaluating Water-Quality Data\n\nLICENSE\n\nhttps://www.usgs.gov/legal\n\nMeprobamate\n\nhttps://water.usgs.gov/water-resources/hbsl/index.html\n\nWHO Anatomical Therapeutic Chemical (ATC) Classification\n\nLICENSE\n\nUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.\n\nhttps://www.whocc.no/copyright_disclaimer/\n\nMeprobamate\n\nhttps://www.whocc.no/atc_ddd_index/?code=N05BC01\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, listing various external databases and authoritative resources relevant to meprobamate, including links to SpringerMaterials, Thieme Chemistry, USGS Health-Based Screening Levels, and the WHO ATC Classification, along with information on their licensing and the specific substance entries.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_135", "document_index": 50, "latency_s": 55.643388999975286, "prompt_toks": 28486, "completion_toks": 88}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.whocc.no/copyright_disclaimer/\n\nMeprobamate\n\nhttps://www.whocc.no/atc_ddd_index/?code=N05BC01\n\nEPA CPDat Classification\n\nhttps://www.whocc.no/atc_ddd_index/\n\nWikidata\n\nLICENSE\n\nCCZero\n\nhttps://creativecommons.org/publicdomain/zero/1.0/\n\nmeprobamate\n\nhttps://www.wikidata.org/wiki/Q418351\n\nWikipedia\n\nMeprobamate\n\nhttps://en.wikipedia.org/wiki/Meprobamate\n\nMedical Subject Headings (MeSH)\n\nLICENSE\n\nWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.\n\nhttps://www.nlm.nih.gov/copyright.html\n\nMeprobamate\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68008620\n\nMeSH Tree\n\nhttp://www.nlm.nih.gov/mesh/meshhome.html\n\nHypnotics and Sedatives\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68006993\n\nAnti-Anxiety Agents\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68014151\n\nAnticonvulsants\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68000927\n\n\n                    Context: \n                    This chunk is from the section listing external data sources and classification systems related to Meprobamate, including links to authoritative databases such as the WHO Anatomical Therapeutic Chemical (ATC) Classification, Wikidata, Wikipedia, Medical Subject Headings (MeSH), and relevant therapeutic classes. It provides reference URLs and copyright information to support further research on Meprobamate's classification, identifiers, and coverage in biomedical and regulatory resources.\n                "}
{"metadata": {"source": "pubchem", "title": "Meprobamate | C9H18N2O4 | CID 4064 - PubChem", "description": "Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/4064", "drug": "Meprobamate", "cid": 4064, "char_count": 102617, "word_count": 13198, "doc_id": "doc_50", "chunk_id": "50::chunk_136", "document_index": 50, "latency_s": 55.96400229999563, "prompt_toks": 28472, "completion_toks": 108}, "content": "Drug: Meprobamate | cid: 4064\nSource: pubchem | Source description: Meprobamate | C9H18N2O4 | CID 4064 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Hypnotics and Sedatives\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68006993\n\nAnti-Anxiety Agents\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68014151\n\nAnticonvulsants\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68000927\n\nMuscle Relaxants, Central\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68009125\n\nPubChem\n\nhttps://pubchem.ncbi.nlm.nih.gov\n\nGHS Classification (UNECE)\n\nGHS Classification\n\nhttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html\n\nEPA Substance Registry Services\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\nEPA SRS List Classification\n\nhttps://maldi.nist.gov\n\nMolGenie\n\nLICENSE\n\nCC-BY 4.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\nMolGenie Organic Chemistry Ontology\n\nhttps://github.com/MolGenie/ontology/\n\nPATENTSCOPE (WIPO)\n\nSID 403383635\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/403383635\n\nNCBI\n\nhttps://www.ncbi.nlm.nih.gov/projects/linkout\n\n\n                    Context: \n                    This chunk is from the section listing authoritative reference sources and classification systems relevant to meprobamate, including Medical Subject Headings (MeSH) pharmacological classes (Hypnotics and Sedatives, Anti-Anxiety Agents, Anticonvulsants, Muscle Relaxants, Central), regulatory databases (PubChem, EPA SRS), international chemical classification systems (GHS UNECE), and database licenses. It provides links to external resources and legal information used elsewhere in the document for substance categorization, safety, and regulatory status.\n                "}
